"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,CA,A,CA 50570 A,052-449-679-076-462,1895-11-13,1895,CA 50570D A,,CA 50570T A,,ELECTRO-DEPOSISTING DEVIC,,BOSSARD JOHN,BOSSARD JOHN,,https://lens.org/052-449-679-076-462,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
2,GB,A,GB 189514031 A,061-754-995-105-568,1895-10-26,1895,GB 189514031D A,1895-07-23,GB 189514031T A,1895-07-23,"Improvements in or relating to Electro-plating, Typing, or Depositing Devices.",,BOSSARD JOHN,BOSSARD JOHN,,https://lens.org/061-754-995-105-568,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
3,US,B2,US 9650997 B2,003-181-486-211-144,2017-05-16,2017,US 201414191926 A,2014-02-27,US 201414191926 A;;US 201361772821 P,2013-03-05,Rotary turbo rocket,"A turbojet is combined with a co-axially integrated rotary rocket to form a propulsion system called a Rotary Turbo Rocket that can function as a turbojet, as an afterburning turbojet, as an Air Turbo Rocket, or as a rotary rocket. The Rotary Turbo Rocket can operate in any of these propulsion modes singularly, or in any combination of these propulsion modes, and can transition continuously or abruptly between operating modes. The Rotary Turbo Rocket can span the zero to orbital flight velocity speed range and/or operate continuously as it transitions from atmospheric to space flight by transitioning between operating modes.",BOSSARD JOHN,BOSSARD JOHN,,https://lens.org/003-181-486-211-144,Granted Patent,yes,29,1,2,2,0,F02K9/78;;F02K9/78;;F02K9/66,F02K9/78;;F02K9/66,,2,0,,,"Hill and Peterson, Mechanics and Thermodynamics of Propulsion, Second Edition, Addison-Wesley Publishing Company, 1992, pp. 400-406.;;Belfiore, Michael, “How a New Engine Could Revolutionize Air and Space Travel”, Popular Mechanics, Feb. 2, 2016, pp. 1-4.",ACTIVE
4,US,A1,US 2015/0007549 A1,078-689-473-715-720,2015-01-08,2015,US 201414191926 A,2014-02-27,US 201414191926 A;;US 201361772821 P,2013-03-05,Rotary Turbo Rocket,"A turbojet is combined with a co-axially integrated rotary rocket to form a propulsion system called a Rotary Turbo Rocket that can function as a turbojet, as an afterburning turbojet, as an Air Turbo Rocket, or as a rotary rocket. The Rotary Turbo Rocket can operate in any of these propulsion modes singularly, or in any combination of these propulsion modes, and can transition continuously or abruptly between operating modes. The Rotary Turbo Rocket can span the zero to orbital flight velocity speed range and/or operate continuously as it transitions from atmospheric to space flight by transitioning between operating modes.",BOSSARD JOHN,BOSSARD JOHN,,https://lens.org/078-689-473-715-720,Patent Application,yes,20,9,2,2,0,F02K9/78;;F02K9/78;;F02K9/66,F02K9/00;;F02K3/00,60/204;;60/246,2,0,,,"Hill and Peterson, Mechanics and Thermodynamics of Propulsion, Second Edition, Addison-Wesley Publishing Company, 1992, pp. 400 - 406.;;Belfiore, Michael, ""How a New Engine Could Revolutionize Air and Space Travel"", Popular Mechanics, February 2, 2016, pp. 1 - 4.",ACTIVE
5,GB,A,GB 189717092 A,087-446-307-942-119,1897-08-21,1897,GB 189717092D A,1897-07-20,GB 189717092T A,1897-07-20,Improvements in or relating to Electro-despositing Devices.,"17,092. Bossard, J. July 20. Cells; electrodes ; electrolytes, agitating.-An annular vessel, formed of sides 1, 2 and bottom 3, is supported upon trestles 4, while in the open space in the centre is supported, by a foot box 23 and traces 24, an upright shaft 29 which receives a slow rotary motion by means of a worm and worm-wheel 41, 40, shaft 43, ratchet-wheel 45, and driving-pawl 47. The pawl receives motion from a shaft 50 by means of a crank 48, adjustable link 44, and counterpoised rocking arm 46 to which the pawl is attached. The shaft 29 supports and carries around the curved arms 31, at the ends of which is a circular rigid carrier 35 having a metal band 36 on its outer side with notches 38. Engaging with these notches are hooks for suspending the articles to be plated in the bath, and also hooks carrying oilers at their lower ends to oil slightly the outer edge of the cathode ring 15, against which rest the hooks carrying the articles to be coated. The cathode ring is carried by brackets 13, and is connected to the negative pole of the dynamo by a wire 16. The anode plates 10 are supported in the electrolyte by carriers 5 connected to metal bands 8, 9 which are joined together by a metal strap 11, and also connected, when desired, to the positive pole of the dynamo. To cause the plating to be uniform on the articles, they are partly rotated, while being carried around the annular vat, by curved arms or clamps 68 supported on the cathode ring 15. By this double movement also the electrolyte is agitated. The operator standing at any point of the circumference of the vat can, without moving, remove all the articles from the vat and re-charge it with fresh articles. Two concentric cathode rings may be used, one on each side of the carrier, in which case the connection to the negative pole may pass through the hollow standard supporting the carrier, or may be made by a trolley travelling on the top of the metal band 15.",BOSSARD JOHN,BOSSARD JOHN,,https://lens.org/087-446-307-942-119,Patent Application,no,0,2,1,1,0,,,,0,0,,,,DISCONTINUED
6,WO,A3,WO 2023/140889 A3,045-345-362-916-603,2023-08-24,2023,US 2022/0035573 W,2022-06-29,US 202163216489 P,2021-06-29,MULTI-MODE COMBINED CYCLE PROPULSION ENGINE,"A turbojet engine capable of operation in an Air Turbo Rocket (ATR) mode includes a compressor, a rotatable turbine wheel comprising turbine blades, a non-rotating guide vane ring comprising guide vanes, a turbine shaft configured to power said compressor, a combustor, a gas generator, and a main combustor. The main combustor is configured to combust hot, fuel rich gas from the gas generator in air compressed by the compressor. Hot, fuel rich gas from the gas generator is directed towards the turbine blades by a directing means.",ATRX INC,BOSSARD JOHN;;BERGMANS JOHN,,https://lens.org/045-345-362-916-603,Search Report,yes,4,0,4,4,0,F02K9/78;;F02K7/18;;F01D5/18;;F01D9/065;;F05D2220/74;;F05D2240/35;;F01D9/041;;F02K9/78;;F05D2240/35;;F05D2220/74;;F05D2240/128;;F02K9/48;;F02K9/08;;F02K9/30;;F02K9/42;;F02K3/12;;F02K9/26;;F02K9/97;;F02K7/18;;F02K7/16;;F02K9/76;;F02K3/10,F01D9/04,,0,0,,,,PENDING
7,WO,A2,WO 2023/140889 A2,099-791-497-044-602,2023-07-27,2023,US 2022/0035573 W,2022-06-29,US 202163216489 P,2021-06-29,MULTI-MODE COMBINED CYCLE PROPULSION ENGINE,"A turbojet engine capable of operation in an Air Turbo Rocket (ATR) mode includes a compressor, a rotatable turbine wheel comprising turbine blades, a non-rotating guide vane ring comprising guide vanes, a turbine shaft configured to power said compressor, a combustor, a gas generator, and a main combustor. The main combustor is configured to combust hot, fuel rich gas from the gas generator in air compressed by the compressor. Hot, fuel rich gas from the gas generator is directed towards the turbine blades by a directing means.",ATRX INC,BOSSARD JOHN;;BERGMANS JOHN,,https://lens.org/099-791-497-044-602,Patent Application,yes,0,0,4,4,0,F02K9/78;;F02K7/18;;F01D5/18;;F01D9/065;;F05D2220/74;;F05D2240/35;;F01D9/041;;F02K9/78;;F05D2240/35;;F05D2220/74;;F05D2240/128;;F02K9/48;;F02K9/08;;F02K9/30;;F02K9/42;;F02K3/12;;F02K9/26;;F02K9/97;;F02K7/18;;F02K7/16;;F02K9/76;;F02K3/10,,,0,0,,,,PENDING
8,US,B2,US 11781507 B2,134-248-794-836-65X,2023-10-10,2023,US 202217853691 A,2022-06-29,US 202217853691 A;;US 202163216489 P,2021-06-29,Multi-mode combined cycle propulsion engine,"A turbojet engine capable of operation in an Air Turbo Rocket (ATR) mode includes a compressor, a rotatable turbine wheel comprising turbine blades, a non-rotating guide vane ring comprising guide vanes, a turbine shaft configured to power said compressor, a combustor, a gas generator, and a main combustor. The main combustor is configured to combust hot, fuel rich gas from the gas generator in air compressed by the compressor. Hot, fuel rich gas from the gas generator is directed towards the turbine blades by a directing means.",ATRX INC,BOSSARD JOHN A;;BERGMANS JOHN L,ATRX INC (2022-06-28),https://lens.org/134-248-794-836-65X,Granted Patent,yes,12,0,4,4,0,F02K9/78;;F02K7/18;;F01D5/18;;F01D9/065;;F05D2220/74;;F05D2240/35;;F01D9/041;;F02K9/78;;F05D2240/35;;F05D2220/74;;F05D2240/128;;F02K9/48;;F02K9/08;;F02K9/30;;F02K9/42;;F02K3/12;;F02K9/26;;F02K9/97;;F02K7/18;;F02K7/16;;F02K9/76;;F02K3/10,F02K7/16;;F01D9/04;;F02K3/10;;F02K3/12;;F02K7/18;;F02K9/08;;F02K9/26;;F02K9/30;;F02K9/42;;F02K9/48;;F02K9/76;;F02K9/78;;F02K9/97,,0,0,,,,ACTIVE
9,US,A1,US 2023/0003135 A1,098-347-345-401-992,2023-01-05,2023,US 202217853691 A,2022-06-29,US 202217853691 A;;US 202163216489 P,2021-06-29,Multi-Mode Combined Cycle Propulsion Engine,"A turbojet engine capable of operation in an Air Turbo Rocket (ATR) mode includes a compressor, a rotatable turbine wheel comprising turbine blades, a non-rotating guide vane ring comprising guide vanes, a turbine shaft configured to power said compressor, a combustor, a gas generator, and a main combustor. The main combustor is configured to combust hot, fuel rich gas from the gas generator in air compressed by the compressor. Hot, fuel rich gas from the gas generator is directed towards the turbine blades by a directing means.",ATRX INC,BOSSARD JOHN A;;BERGMANS JOHN L,ATRX INC (2022-06-28),https://lens.org/098-347-345-401-992,Patent Application,yes,12,0,4,4,0,F02K9/78;;F02K7/18;;F01D5/18;;F01D9/065;;F05D2220/74;;F05D2240/35;;F01D9/041;;F02K9/78;;F05D2240/35;;F05D2220/74;;F05D2240/128;;F02K9/48;;F02K9/08;;F02K9/30;;F02K9/42;;F02K3/12;;F02K9/26;;F02K9/97;;F02K7/18;;F02K7/16;;F02K9/76;;F02K3/10,F01D9/04;;F01D5/18;;F02K9/78,,0,0,,,,ACTIVE
10,US,B2,US 8193846 B2,122-703-138-041-687,2012-06-05,2012,US 51020009 A,2009-07-27,US 51020009 A;;US 96158404 A;;US 51074803 P,2003-10-10,Selectable delay pulse generator,"A programmable pulse generator having a clock signal delay chain, multiplexer, and reduced voltage charge circuit. The clock delay chain comprises a plurality of propagated delays, coupled to the multiplexer. The multiplexer selects a particular clock delay signal from a plurality of delay chain taps. The multiplexer is driven by a tap select register coupled to a state machine. The state machine controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer.",FAGAN JOHN L;;BOSSARD MARK;;ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK,ATMEL CORPORATION (2004-11-09),https://lens.org/122-703-138-041-687,Granted Patent,yes,53,2,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,327/276;;327/277,2,0,,,"""8:1 MUX/DEMUX BusSwitch Data Sheet"", Pericom Semiconductor Corp., (1996), 1-3.;;""International Application Serial No. PCT/US2004/033341, International Search Report mailed Oct. 5, 2004"", 1 pg.",INACTIVE
11,EP,A4,EP 1673865 A4,045-971-317-181-861,2006-12-20,2006,EP 04794610 A,2004-10-08,US 2004/0033309 W;;US 51071003 P,2003-10-10,REDUCED VOLTAGE PRE-CHARGE MULTIPLEXER,,ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/045-971-317-181-861,Search Report,no,3,0,10,10,0,H03K17/693;;H03K17/693,H03K17/693,,0,0,,,,DISCONTINUED
12,US,A,US 3635302 A,058-716-963-924-096,1972-01-18,1972,US 3635302D A,1969-12-19,US 88647369 A,1969-12-19,VEHICLE BODY COUPLING,A vehicle having front and rear body units rotatably connected by a body coupling for rotational movement about an axis parallel to the longitudinal axis of the vehicle. The coupling includes a hollow male member carried on the rear wall of the front body unit and extends through a sleeve carried on the front wall of the rear body with each being rigidly connected to their respective body walls by mounting plates. A plurality of bolt members extend outwardly from the inner peripheral surface of the hollow male member and extend through an end plate adapted to limit longitudinal movement of the sleeve on the male member. Wear plates are provided between the adjacent front and rear body walls and the end plate may be tightened against the sleeve as it is appropriate to compensate for wear on the wear plates.,STANDARD ENGINEERING CO INC,ROGERS JOHN A;;BOSSARD FREDRICK R,,https://lens.org/058-716-963-924-096,Granted Patent,no,6,12,1,1,0,B62D21/18;;B62D53/028;;B62D53/028;;B62D21/18,B62D21/18;;B62D53/02,180 44   R;;280/111;;280/504,0,0,,,,EXPIRED
13,CN,A,CN 1954497 A,157-618-369-765-790,2007-04-25,2007,CN 200480033589 A,2004-10-08,US 51071003 P,2003-10-10,Reduced voltage pre-charge multiplexer,,ATMEL CORP,FAGAN JOHN L BOSSARD MARK A,,https://lens.org/157-618-369-765-790,Patent Application,no,0,1,10,10,0,H03K17/693;;H03K17/693,H03K17/62;;H03K17/693,,0,0,,,,DISCONTINUED
14,EP,A2,EP 1673865 A2,183-176-362-366-591,2006-06-28,2006,EP 04794610 A,2004-10-08,US 2004/0033309 W;;US 51071003 P,2003-10-10,REDUCED VOLTAGE PRE-CHARGE MULTIPLEXER,,ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/183-176-362-366-591,Patent Application,yes,0,0,10,10,0,H03K17/693;;H03K17/693,H03K17/693,,0,0,,,,DISCONTINUED
15,US,A1,US 2005/0077939 A1,000-713-753-451-085,2005-04-14,2005,US 96227604 A,2004-10-08,US 96227604 A;;US 51071003 P,2003-10-10,Reduced voltage pre-charge multiplexer,"An electronic device selects one of a plurality of input signals for coupling to an output channel. Individual pulldowns provide a separate pathway for each input, and are coupled to a common node which is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",FAGAN JOHN L.;;BOSSARD MARK A.,FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORAITON (2004-11-09),https://lens.org/000-713-753-451-085,Patent Application,yes,4,2,10,10,0,H03K17/693;;H03K17/693,H03K17/693,327/172,0,0,,,,ACTIVE
16,WO,A3,WO 2005/036747 A3,058-044-548-781-332,2006-02-23,2006,US 2004/0033341 W,2004-10-08,US 51074803 P,2003-10-10,SELECTABLE DELAY PULSE GENERATOR,"A programmable pulse generator (100) having a clock signal delay chain (10), multiplexer (20), and reduced voltage charge circuit (60). The clock delay chain (10) comprises a plurality of propagated delays, coupled to the multiplexer (20). The multiplexer (20) selects a particular clock delay signal from a plurality of delay chain taps (12). The multiplexer (20) is driven by a tap select register (30) coupled to a state machine (40). The state machine (40) controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer (20) are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer (20).",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/058-044-548-781-332,Search Report,yes,3,0,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,,0,0,,,,PENDING
17,US,A1,US 2005/0077941 A1,006-234-383-608-910,2005-04-14,2005,US 96158404 A,2004-10-08,US 96158404 A;;US 51074803 P,2003-10-10,Selectable delay pulse generator,"A programmable pulse generator having a clock signal delay chain, multiplexer, and reduced voltage charge circuit. The clock delay chain comprises a plurality of propagated delays, coupled to the multiplexer. The multiplexer selects a particular clock delay signal from a plurality of delay chain taps. The multiplexer is driven by a tap select register coupled to a state machine. The state machine controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer.",FAGAN JOHN L.;;BOSSARD MARK A.,FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORATION (2004-11-09),https://lens.org/006-234-383-608-910,Patent Application,yes,7,6,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,327/276,0,0,,,,DISCONTINUED
18,EP,A2,EP 1673862 A2,114-543-302-390-644,2006-06-28,2006,EP 04794638 A,2004-10-08,US 2004/0033341 W;;US 51074803 P,2003-10-10,SELECTABLE DELAY PULSE GENERATOR,,ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/114-543-302-390-644,Patent Application,yes,0,0,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;G06F1/04;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,,1,0,,,See references of WO 2005036747A3,DISCONTINUED
19,CN,A,CN 1951010 A,104-568-203-117-78X,2007-04-18,2007,CN 200480033562 A,2004-10-08,US 51074803 P,2003-10-10,Selectable delay pulse generator,,ATMEL CORP,FAGAN JOHN L BOSSARD MARK A,,https://lens.org/104-568-203-117-78X,Patent Application,no,0,0,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;G06F1/04;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,,0,0,,,,DISCONTINUED
20,CA,A,CA 908571 A,122-605-850-070-810,1972-08-29,1972,CA 908571D A,,CA 908571T A,,VEHICLE REAR WHEEL DRIVE ASSEMBLY,,STANDARD ENGINEERING CO,BOSSARD FREDRICK R;;ROGERS JOHN A,,https://lens.org/122-605-850-070-810,Granted Patent,no,0,0,1,1,0,,B60F3/00;;B60K17/28;;B62D21/18;;B62D49/06;;B62D53/02,,0,0,,,,EXPIRED
21,US,A1,US 2007/0069785 A1,103-407-640-607-767,2007-03-29,2007,US 55981006 A,2006-11-14,US 55981006 A;;US 96227604 A;;US 51071003 P,2003-10-10,REDUCED VOLTAGE PRE-CHARGE MULTIPLEXER,"An electronic device selects one of a plurality of input signals for coupling to an output channel. Individual pulldowns provide a separate pathway for each input, and are coupled to a common node which: is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/103-407-640-607-767,Patent Application,yes,10,0,10,10,0,H03K17/693;;H03K17/693,H03K3/017;;H03K17/693,327/172,0,0,,,,ACTIVE
22,US,A,US 3664451 A,088-324-925-103-364,1972-05-23,1972,US 3664451D A,1970-01-26,US 574070 A,1970-01-26,VEHICLE REAR WHEEL DRIVE ASSEMBLY,A vehicle having front and rear body sections rotatably interconnected along the longitudinal axis of the body sections. An engine is located in the front body section and a drive shaft extends through the coupling between the body sections through the compartment of the rear body section and to a gear box on a rear axle located entirely outside of the compartment of the rear body section. The rear axle is supported by frame members extending rearwardly from the rear body section. A wall extends horizontally over the rear axle and provides a seat for the compartment in the rear body section. A propeller may be connected to a drive shaft extending rearwardly from the gear box on the rear axle.,STANDARD ENGINEERING CO INC,ROGERS JOHN A;;BOSSARD FREDRICK R,,https://lens.org/088-324-925-103-364,Granted Patent,no,6,12,1,1,0,B62D21/18;;B62D21/18;;B60F3/0007;;B60F3/0007;;B62D49/0664;;B62D49/0664;;B62D53/028;;B62D53/028,B60F3/00;;B62D21/18;;B62D49/06;;B62D53/02,180 70   R;;115  1   R,0,0,,,,EXPIRED
23,TW,A,TW 200520388 A,059-338-278-090-805,2005-06-16,2005,TW 93130683 A,2004-10-08,US 51074803 P,2003-10-10,Selectable delay pulse generator,"A programmable pulse generator having a clock signal delay chain, multiplexer, and reduced voltage charge circuit. The clock delay chain comprises a plurality of propagated delays, coupled to the multiplexer. The multiplexer selects a particular clock delay signal from a plurality of delay chain taps. The multiplexer is driven by a tap select register coupled to a state machine. The state machine controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/059-338-278-090-805,Patent of Addition,no,0,0,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,,0,0,,,,PENDING
24,WO,A2,WO 2005/036747 A2,036-246-246-121-926,2005-04-21,2005,US 2004/0033341 W,2004-10-08,US 51074803 P,2003-10-10,SELECTABLE DELAY PULSE GENERATOR,"A programmable pulse generator (100) having a clock signal delay chain (10), multiplexer (20), and reduced voltage charge circuit (60). The clock delay chain (10) comprises a plurality of propagated delays, coupled to the multiplexer (20). The multiplexer (20) selects a particular clock delay signal from a plurality of delay chain taps (12). The multiplexer (20) is driven by a tap select register (30) coupled to a state machine (40). The state machine (40) controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer (20) are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer (20).",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/036-246-246-121-926,Patent Application,yes,0,1,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,,0,0,,,,PENDING
25,US,A,US 3659667 A,121-109-429-238-561,1972-05-02,1972,US 3659667D A,1969-12-19,US 88647269 A,1969-12-19,VEHICLE FRONT WHEEL DRIVE ASSEMBLY,A drive assembly for a front wheel drive vehicle wherein a gear box is connected by a drive shaft and in turn provides driven shafts extending in opposite directions for connection with separate clutches which in turn are connected to the respective front wheels. Each of the clutches includes a pair of jaw portions semicylindrical in shape when in engagement with each other form a cylindrical drive member. Each of the jaw members are keyed to separate shafts for rotation therewith and an actuating lever is connected to a yoke in turn connected to one of the jaw members for sliding it along its shaft into and out of engagement with the other axially stationary jaw.,STANDARD ENGINEERING CO INC,ROGERS JOHN A;;BOSSARD FREDRICK R,,https://lens.org/121-109-429-238-561,Granted Patent,no,8,1,1,1,0,B60F3/0007;;B60F3/0007;;B60K17/30;;B60K17/30,B60F3/00;;B60K17/30,180/6.2;;192/108;;192/114,0,0,,,,EXPIRED
26,AU,A,AU 1972/038755 A,146-233-170-635-52X,1973-08-09,1973,AU 1972/038755 A,1972-02-07,AU 1972/038755 A,1972-02-07,VEHICLE BODY COUPLING,,STANDARD ENGINEERING CO INC,ROGERS JOHN ARCHIE;;BOSSARD FREDRICK ROBERT,,https://lens.org/146-233-170-635-52X,Patent Application,no,0,0,1,1,0,,B62D63/00;;F16D3/00,,0,0,,,,DISCONTINUED
27,US,B2,US 7157958 B2,065-678-444-697-361,2007-01-02,2007,US 96227604 A,2004-10-08,US 96227604 A;;US 51071003 P,2003-10-10,Reduced voltage pre-charge multiplexer,"An electronic device selects one of a plurality of input signals for coupling to an output channel. Individual pulldowns provide a separate pathway for each input, and are coupled to a common node which is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORAITON (2004-11-09),https://lens.org/065-678-444-697-361,Granted Patent,yes,4,3,10,10,0,H03K17/693;;H03K17/693,H03K17/00;;H03K17/693,327/407;;327/99,0,0,,,,ACTIVE
28,US,A1,US 2009/0284296 A1,077-282-790-493-278,2009-11-19,2009,US 51020009 A,2009-07-27,US 51020009 A;;US 96158404 A;;US 51074803 P,2003-10-10,SELECTABLE DELAY PULSE GENERATOR,"A programmable pulse generator having a clock signal delay chain, multiplexer, and reduced voltage charge circuit. The clock delay chain comprises a plurality of propagated delays, coupled to the multiplexer. The multiplexer selects a particular clock delay signal from a plurality of delay chain taps. The multiplexer is driven by a tap select register coupled to a state machine. The state machine controls the programmable pulse output, encoding the data by varying the pulse width and delay between pulses. The delay of pulse outputs from the multiplexer are reduced by coupling a reduced voltage pre-charge circuit to the multiplexer.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORATION (2004-11-09),https://lens.org/077-282-790-493-278,Patent Application,yes,52,1,8,8,0,H03K7/08;;H03K7/08;;H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K/;;H03K5/00;;H03K5/13;;H03K7/08,327/276,0,0,,,,INACTIVE
29,WO,A2,WO 2005/034607 A2,011-210-642-326-18X,2005-04-21,2005,US 2004/0033309 W,2004-10-08,US 51071003 P,2003-10-10,REDUCED VOLTAGE PRE-CHARGE MULTIPLEXER,"An electronic device (200) selects one of a plurality of input signals (I0, Il) for coupling to an output channel (OUT). Individual pulldowns provide a separate pathway for each input (I0, Il), and are coupled to a common node which is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/011-210-642-326-18X,Patent Application,yes,0,0,10,10,0,H03K17/693;;H03K17/693,H03K17/693,,1,0,,,See references of EP 1673865A4,PENDING
30,AU,A,AU 1972/038754 A,027-245-043-815-871,1973-08-09,1973,AU 1972/038754 A,1972-02-07,AU 1972/038754 A,1972-02-07,VEHICLE REAR WHEEL DRIVE ASSEMBLY,,STANDARD ENGINEERING CO INC,ROGERS JOHN ARCHIE;;BOSSARD FREDRICK ROBERT,,https://lens.org/027-245-043-815-871,Patent Application,no,0,0,1,1,0,B60F3/0007,B60F3/00,,0,0,,,,DISCONTINUED
31,CA,A,CA 910197 A,014-514-896-430-464,1972-09-19,1972,CA 910197D A,,CA 910197T A,,VEHICLE BODY COUPLING,,STANDARD ENGINEERING CO,ROGERS JOHN A;;BOSSARD FREDRICK R,,https://lens.org/014-514-896-430-464,Granted Patent,no,0,0,1,1,0,,B60D1/00;;B62D21/18;;B62D53/02,,0,0,,,,EXPIRED
32,US,B2,US 7471132 B2,047-203-110-168-070,2008-12-30,2008,US 55981006 A,2006-11-14,US 55981006 A;;US 96227604 A;;US 51071003 P,2003-10-10,Reduced voltage pre-charge multiplexer,"An electronic device selects one of a plurality of input signals for coupling to an output channel. Individual pulldowns provide a separate pathway for each input, and are coupled to a common node which: is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/047-203-110-168-070,Granted Patent,yes,9,2,10,10,0,H03K17/693;;H03K17/693,H03K3/017;;H03K17/693,327/172;;327/175,0,0,,,,ACTIVE
33,WO,A3,WO 2005/034607 A3,154-813-079-632-687,2005-12-29,2005,US 2004/0033309 W,2004-10-08,US 51071003 P,2003-10-10,REDUCED VOLTAGE PRE-CHARGE MULTIPLEXER,"An electronic device (200) selects one of a plurality of input signals (I0, Il) for coupling to an output channel (OUT). Individual pulldowns provide a separate pathway for each input (I0, Il), and are coupled to a common node which is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/154-813-079-632-687,Search Report,yes,1,0,10,10,0,H03K17/693;;H03K17/693,H03K17/693,,1,0,,,See also references of EP 1673865A4,PENDING
34,US,A,US 4711118 A,178-831-688-056-910,1987-12-08,1987,US 31833081 A,1981-11-05,US 31833081 A,1981-11-05,Detection of water entrapped in electronic components,"The accuracy of measurements made to determine the extent of water vapor trapped upon encapsulation of an electronic device is significantly enhanced by carefully controlling the measurement technique employed. In particular, the encapsulant is generally punctured and the water vapor thus released is monitored. It has been found that to obtain an accurate measurement of the magnitude of the water vapor released, this measurement must be made within 0.1 second of the time of encapsulant punctured and released into a glass system. By using an absorption technique with suitable electronics, this time requirement is fulfilled and significantly more accurate quantitative measurements of entrapped water vapor are obtained.",AMERICAN TELEPHONE & TELEGRAPH,BOSSARD PETER R;;MUCHA JOHN A,BELL TELEPHONE LABORATORIES INCORPORATED A CORP. OF NY (1981-11-04),https://lens.org/178-831-688-056-910,Granted Patent,yes,5,7,1,1,0,G01N21/3554;;G01N21/39;;G01N21/94;;G01N21/94;;G01N21/3554;;G01N21/39,G01N21/35;;G01N21/39;;G01N21/94,73/73;;73/52;;356/256,0,0,,,,EXPIRED
35,TW,A,TW 200527816 A,032-130-833-355-874,2005-08-16,2005,TW 93130807 A,2004-10-08,US 51071003 P,2003-10-10,Reduced voltage pre-charge multiplexer,"An electronic device selects one of a plurality of input signals for coupling to an output channel. Individual pulldowns provide a separate pathway for each input, and are coupled to a common node which is pre-charged to a voltage less than a system voltage. Each pulldown is coupled to a select line for gating an associated input signal.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/032-130-833-355-874,Patent of Addition,no,0,2,10,10,0,H03K17/693;;H03K17/693,H03K17/693,,0,0,,,,PENDING
36,CA,A,CA 916606 A,197-054-716-360-617,1972-12-12,1972,CA 916606D A,,CA 916606T A,,VEHICLE FRONT WHEEL DRIVE ASSEMBLY,,STANDARD ENGINEERING CO,ROGERS JOHN A;;BOSSARD FREDRICK R,,https://lens.org/197-054-716-360-617,Granted Patent,no,0,0,1,1,0,,B60F3/00;;B60K17/30;;B62D11/08,,0,0,,,,EXPIRED
37,CN,A,CN 1879301 A,121-953-161-352-913,2006-12-13,2006,CN 200480033336 A,2004-10-05,US 51073703 P,2003-10-10,Vernier circuit for fine control of sample time,"A vernier time shifting circuit 100 is used for fine-tuning capture of a clock signal and/or a data signal to compensate for fluctuations produced by the system or other variations within non-time invariant parts of the chip. Other variations can include process, temperature, or voltage differences. The vernier sample time shifting circuit 100 allows shifting the signal in small steps to allow for optimal sampling. Various amounts of delay of the time-shifted signal are available at a plurality of output delay taps 113.",ATMEL CORP,FAGAN JOHN L BOSSARD MARK A CO,,https://lens.org/121-953-161-352-913,Patent Application,no,0,0,1,6,0,,H03H11/26,,0,0,,,,DISCONTINUED
38,WO,A3,WO 2005/039054 A3,045-847-015-914-363,2005-08-04,2005,US 2004/0032871 W,2004-10-05,US 51073803 P;;US 83670304 A,2003-10-10,DUAL PHASE PULSE MODULATION ENCODER CIRCUIT,"An dual phase pulse modulation (DPPM) encoder circuit (Fig. 3) converts data (11) into a series of high and low signal pulses (33; Fig. 2B), each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers (13A, 13B) that subdivide received data words into the M-bit groups, a state machine (19) that specifies the pulse durations for each received group, e.g., by incrementing a state (STATE (i)) that indicates selected signal pulse transition (TAP &lowbar; SELECT ⏧45:0&rsqb;) times, a system clock delay chain (27) with multiple taps (T2 T92), a multiplexer (25) controlled (23) by the state machine for successively selecting different taps, and a toggle flip-flop (31) that is clocked by the multiplexer output (TAP&lowbar;POINT, 29) .",ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/045-847-015-914-363,Search Report,yes,3,0,7,9,0,H03M5/08;;H03M5/08,H03M/;;H03M5/06;;H03M5/08;;H04L27/04;;H04L27/12;;H04L27/20,,1,0,,,See also references of EP 1673914A4,PENDING
39,US,A1,US 2011/0151883 A1,082-894-785-462-387,2011-06-23,2011,US 200913058572 A,2009-08-07,EP 08305478 A;;IB 2009053474 W,2008-08-14,"METHOD FOR COMMUNICATING IN A NETWORK, A SECONDARY STATION AND A SYSTEM THEREFOR","The present invention relates to a method for communicating in a network, comprising a) a secondary station preparing the transmission to a primary station of a message comprising a report and a data field for containing data in an allocated resource, and b) the secondary station setting at least one transmission parameter of the message at a first level of reliability if the size of the allocated resource is bigger than the size of the message, and else setting at least one transmission parameter at second level of reliability being lower than the first level of reliability, c) the secondary station transmitting the message to the primary station.",KONINKL PHILIPS ELECTRONICS NV,BOSSARD GILDAS;;MOULSLEY TIMOTHY JAMES;;BAKER MATTHEW PETER JOHN,KONINKLIJKE PHILIPS ELECTRONICS N.V (2009-11-09),https://lens.org/082-894-785-462-387,Patent Application,yes,11,8,7,7,0,H04L1/0067;;H04L1/0083;;H04L1/08;;H04L47/30;;H04L47/35;;H04L47/38;;H04W28/12;;H04W28/14;;H04W28/18;;H04W48/08;;H04W28/0252;;H04W28/0278;;H04L1/08;;H04W28/0278;;H04W28/18;;H04L47/38;;H04L47/26;;H04L1/0003;;H04W72/543;;H04W52/26;;H04W28/18;;H04L47/30;;H04W28/12;;H04L1/0083;;H04L47/38;;H04L1/08;;H04L47/10;;H04W28/14;;H04L47/26;;H04L47/35;;H04W48/08;;H04L1/0067;;H04W8/04,H04W72/04,455/450,0,0,,,,DISCONTINUED
40,US,A1,US 2005/0078021 A1,090-585-712-057-365,2005-04-14,2005,US 83670304 A,2004-04-29,US 83670304 A;;US 51073803 P,2003-10-10,Dual phase pulse modulation encoder circuit,"An dual phase pulse modulation (DPPM) encoder circuit converts data into a series of high and low signal pulses, each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers that subdivide received data words into the M-bit groups, a state machine that specified the pulse durations for each received group, e.g., by incrementing a state that indicates selected signal pulse transition times, a system clock delay chain with multiple taps, a multiplexer controlled by the state machine for successively selecting different taps, and a toggle flip-flop that is clocked by the multiplexer output.",COHEN DANIEL S.;;FAGAN JOHN L.;;BOSSARD MARK A.,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORATION (2004-04-27),https://lens.org/090-585-712-057-365,Patent Application,yes,41,28,7,9,0,H03M5/08;;H03M5/08,H03M/;;H03M5/06;;H03M5/08;;H04L27/04;;H04L27/12;;H04L27/20,341/68;;341/53,0,0,,,,ACTIVE
41,EP,A2,EP 1673914 A2,155-722-408-216-40X,2006-06-28,2006,EP 04794278 A,2004-10-05,US 2004/0032871 W;;US 51073803 P;;US 83670304 A,2003-10-10,DUAL PHASE PULSE MODULATION ENCODER CIRCUIT,,ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/155-722-408-216-40X,Patent Application,yes,0,0,7,9,0,H03M5/08;;H03M5/08,H03M/;;H03M5/06;;H03M5/08;;H04L27/04;;H04L27/12;;H04L27/20,,0,0,,,,DISCONTINUED
42,US,B2,US 7233185 B2,156-462-942-340-812,2007-06-19,2007,US 83747804 A,2004-04-29,US 83747804 A;;US 51073703 P,2003-10-10,Vernier circuit for fine control of sample time,"A vernier time shifting circuit is used for fine-tuning capture of a clock signal and/or a data signal to compensate for fluctuations produced by the system or other variations within non-time invariant parts of the chip. Other variations can include process, temperature, or voltage differences. The vernier sample time shifting circuit allows shifting the signal in small steps to allow for optimal sampling.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A;;COHEN DANIEL S,ATMEL CORPORATION (2004-04-27),https://lens.org/156-462-942-340-812,Granted Patent,yes,14,0,5,6,0,H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K5/00;;H03K5/13,327/271;;327/284,0,0,,,,INACTIVE
43,EP,A1,EP 1673861 A1,165-798-506-047-359,2006-06-28,2006,EP 04794283 A,2004-10-05,US 2004/0032876 W;;US 51073703 P;;US 83747804 A,2003-10-10,VERNIER CIRCUIT FOR FINE CONTROL OF SAMPLE TIME,,ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A;;COHEN DANIEL S,,https://lens.org/165-798-506-047-359,Patent Application,yes,0,0,5,6,0,H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K5/00;;H03K5/13,,1,0,,,See references of WO 2005039047A1,DISCONTINUED
44,CN,C,CN 100589464 C,021-827-526-093-684,2010-02-10,2010,CN 200480033585 A,2004-10-05,US 51073803 P,2003-10-10,Dual phase pulse modulation encoder circuit,"An dual phase pulse modulation (DPPM) encoder circuit (Fig. 3) converts data (11) into a series of high and low signal pulses (33; Fig. 2B), each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers (13A, 13B) that subdividereceived data words into the M-bit groups, a state machine (19) that specifies the pulse durations for each received group, e.g., by incrementing a state (STATE (i)) that indicates selected signal pulse transition (TAP _ SELECT [45:0]) times, a system clock delay chain (27) with multiple taps (T2 T92), a multiplexer (25) controlled (23) by the state machine for successively selecting different taps, and a toggle flip-flop (31) that is clocked by the multiplexer output (TAP_POINT, 29).",ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/021-827-526-093-684,Granted Patent,no,0,0,2,9,0,,H04L27/04,,0,0,,,,INACTIVE
45,WO,A1,WO 2005/039047 A1,050-984-442-185-902,2005-04-28,2005,US 2004/0032876 W,2004-10-05,US 51073703 P;;US 83747804 A,2003-10-10,VERNIER CIRCUIT FOR FINE CONTROL OF SAMPLE TIME,"A vernier time shifting circuit 100 is used for fine-tuning capture of a clock signal and/or a data signal to compensate for fluctuations produced by the system or other variations within non-time invariant parts of the chip. other variations can include process, temperature, or voltage differences. The vernier sample time shifting circuit 100 allows shifting the signal in small steps to allow for optimal sampling. Various amounts of delay of the time-shifted signal are available at a plurality of output delay taps 113.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A;;COHEN DANIEL S,,https://lens.org/050-984-442-185-902,Patent Application,yes,1,0,5,6,0,H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K5/00;;H03K5/13,,0,0,,,,PENDING
46,US,B2,US 7103110 B2,169-446-539-911-795,2006-09-05,2006,US 83670304 A,2004-04-29,US 83670304 A;;US 51073803 P,2003-10-10,Dual phase pulse modulation encoder circuit,"An dual phase pulse modulation (DPPM) encoder circuit converts data into a series of high and low signal pulses, each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers that subdivide received data words into the M-bit groups, a state machine that specified the pulse durations for each received group, e.g., by incrementing a state that indicates selected signal pulse transition times, a system clock delay chain with multiple taps, a multiplexer controlled by the state machine for successively selecting different taps, and a toggle flip-flop that is clocked by the multiplexer output.",ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,ATMEL CORPORATION (2004-04-27),https://lens.org/169-446-539-911-795,Granted Patent,yes,41,6,7,9,0,H03M5/08;;H03M5/08,H04L27/04;;H03M/;;H03M5/06;;H03M5/08;;H04L27/12;;H04L27/20,375/295,0,0,,,,ACTIVE
47,US,A1,US 2005/0077942 A1,151-544-927-898-428,2005-04-14,2005,US 83747804 A,2004-04-29,US 83747804 A;;US 51073703 P,2003-10-10,Vernier circuit for fine control of sample time,"A vernier time shifting circuit is used for fine-tuning capture of a clock signal and/or a data signal to compensate for fluctuations produced by the system or other variations within non-time invariant parts of the chip. Other variations can include process, temperature, or voltage differences. The vernier sample time shifting circuit allows shifting the signal in small steps to allow for optimal sampling.",FAGAN JOHN L.;;BOSSARD MARK A.;;COHEN DANIEL S.,FAGAN JOHN L;;BOSSARD MARK A;;COHEN DANIEL S,ATMEL CORPORATION (2004-04-27),https://lens.org/151-544-927-898-428,Patent Application,yes,14,0,5,6,0,H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K5/00;;H03K5/13,327/277,0,0,,,,INACTIVE
48,EP,A4,EP 1673914 A4,088-588-305-567-191,2007-12-19,2007,EP 04794278 A,2004-10-05,US 2004/0032871 W;;US 51073803 P;;US 83670304 A,2003-10-10,DUAL PHASE PULSE MODULATION ENCODER CIRCUIT,,ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/088-588-305-567-191,Search Report,no,3,0,7,9,0,H03M5/08;;H03M5/08,H04L27/04;;H03M/;;H03M5/06;;H03M5/08;;H04L27/12;;H04L27/20,,0,0,,,,DISCONTINUED
49,WO,A2,WO 2005/039054 A2,057-532-594-612-501,2005-04-28,2005,US 2004/0032871 W,2004-10-05,US 51073803 P;;US 83670304 A,2003-10-10,DUAL PHASE PULSE MODULATION ENCODER CIRCUIT,"An dual phase pulse modulation (DPPM) encoder circuit (Fig. 3) converts data (11) into a series of high and low signal pulses (33; Fig. 2B), each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers (13A, 13B) that subdivide received data words into the M-bit groups, a state machine (19) that specifies the pulse durations for each received group, e.g., by incrementing a state (STATE (i)) that indicates selected signal pulse transition (TAP &lowbar; SELECT ⏧45:0&rsqb;) times, a system clock delay chain (27) with multiple taps (T2 T92), a multiplexer (25) controlled (23) by the state machine for successively selecting different taps, and a toggle flip-flop (31) that is clocked by the multiplexer output (TAP&lowbar;POINT, 29) .",ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/057-532-594-612-501,Patent Application,yes,0,0,7,9,0,H03M5/08;;H03M5/08,H03M/;;H03M5/06;;H03M5/08;;H04L27/04;;H04L27/12;;H04L27/20,,1,0,,,See references of EP 1673914A4,PENDING
50,TW,A,TW 200516854 A,114-439-828-216-704,2005-05-16,2005,TW 93130529 A,2004-10-08,US 51073803 P;;US 83670304 A,2003-10-10,Dual phase pulse modulation encoder circuit,"An dual phase pulse modulation (DPPM) encoder circuit converts data into a series of high and low signal pulses, each of whose time durations or pulse widths represents a group of M data bits, with the alternating high and low pulses representing successive groups. The encoder circuit may include a set of parallel-in, serial-out shift registers that subdivide received data words into the M-bit groups, a state machine that specified the pulse durations for each received group, e.g., by incrementing a state that indicates selected signal pulse transition times, a system clock delay chain with multiple taps, a multiplexer controlled by the state machine for successively selecting different taps, and a toggle flip-flop that is clocked by the multiplexer output.",ATMEL CORP,COHEN DANIEL S;;FAGAN JOHN L;;BOSSARD MARK A,,https://lens.org/114-439-828-216-704,Patent of Addition,no,0,0,7,9,0,H03M5/08;;H03M5/08,H03M/;;H03M5/06;;H03M5/08;;H04L27/04;;H04L27/12;;H04L27/20,,0,0,,,,PENDING
51,TW,A,TW 200525552 A,010-348-393-473-781,2005-08-01,2005,TW 93130184 A,2004-10-06,US 51073703 P;;US 83747804 A,2003-10-10,Vernier circuit for fine control of sample time,"A vernier time shifting circuit is used for fine-tuning capture of a clock signal and/or a data signal to compensate for fluctuations produced by the system or other variations within non-time invariant parts of the chip. Other variations can include process, temperature, or voltage differences. The vernier sample time shifting circuit allows shifting the signal in small steps to allow for optimal sampling.",ATMEL CORP,FAGAN JOHN L;;BOSSARD MARK A;;COHEN DANIEL S,,https://lens.org/010-348-393-473-781,Patent of Addition,no,0,0,5,6,0,H03K5/133;;H03K5/133;;H03K2005/00058;;H03K2005/00058;;H03K2005/00156;;H03K2005/00156,H03H11/26;;H03K5/00;;H03K5/13,,0,0,,,,PENDING
52,US,A1,US 2023/0000842 A1,065-900-897-571-256,2023-01-05,2023,US 202017423761 A,2020-01-17,US 202017423761 A;;US 201962793855 P;;US 2020/0013995 W,2019-01-17,METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK,"Provided herein are methods of treating cartilage disorders in a subject using a dual CLK/DYRK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, or a combination of a CLK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, and DYRK inhibitor or, pharmaceutically acceptable salt or solvate thereof.",SAMUMED LLC,DESHMUKH VISHAL;;O'GREEN ALYSSA-LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,SAMUMED LLC (2020-09-17);;BIOSPLICE THERAPEUTICS INC (2021-03-05),https://lens.org/065-900-897-571-256,Patent Application,yes,0,2,4,4,49,A61K31/4155;;A61K31/44;;A61K31/47;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/4725;;A61K31/519;;A61P19/02;;Y02A50/30;;A61K31/416;;A61K31/427;;A61K31/437;;A61K31/438;;A61K31/4439;;A61K31/444;;A61K31/496;;A61K31/497;;A61K31/4985;;A61K31/501;;A61K31/5386;;A61K31/541;;A61K31/55;;G01N33/6893;;G01N2800/105,A61K31/438;;A61K31/416;;A61K31/427;;A61K31/437;;A61K31/4439;;A61K31/444;;A61K31/496;;A61K31/497;;A61K31/4985;;A61K31/501;;A61K31/5386;;A61K31/541;;A61K31/55;;G01N33/68,,0,0,,,,PENDING
53,EP,A2,EP 3911317 A2,038-251-948-304-021,2021-11-24,2021,EP 20704766 A,2020-01-17,US 201962793855 P;;US 2020/0013995 W,2019-01-17,METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK,,BIOSPLICE THERAPEUTICS INC,DESHMUKH VISHAL;;O'GREEN ALYSSA-LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,,https://lens.org/038-251-948-304-021,Patent Application,yes,0,0,4,4,0,A61K31/4155;;A61K31/44;;A61K31/47;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/4725;;A61K31/519;;A61P19/02;;Y02A50/30;;A61K31/416;;A61K31/427;;A61K31/437;;A61K31/438;;A61K31/4439;;A61K31/444;;A61K31/496;;A61K31/497;;A61K31/4985;;A61K31/501;;A61K31/5386;;A61K31/541;;A61K31/55;;G01N33/6893;;G01N2800/105,A61K31/4155;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/44;;A61K31/47;;A61K31/4725;;A61K31/519;;A61P19/02,,0,0,,,,DISCONTINUED
54,WO,A2,WO 2020/150552 A2,195-057-181-017-935,2020-07-23,2020,US 2020/0013995 W,2020-01-17,US 201962793855 P,2019-01-17,METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK,"Provided herein are methods of treating cartilage disorders in a subject using a dual CLK/DYRK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, or a combination of a CLK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, and DYRK inhibitor or, pharmaceutically acceptable salt or solvate thereof.",SAMUMED LLC;;DESHMUKH VISHAL;;OGREEN ALYSSA LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,DESHMUKH VISHAL;;O'GREEN ALYSSA-LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,,https://lens.org/195-057-181-017-935,Patent Application,yes,36,9,4,4,49,A61K31/4155;;A61K31/44;;A61K31/47;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/4725;;A61K31/519;;A61P19/02;;Y02A50/30;;A61K31/416;;A61K31/427;;A61K31/437;;A61K31/438;;A61K31/4439;;A61K31/444;;A61K31/496;;A61K31/497;;A61K31/4985;;A61K31/501;;A61K31/5386;;A61K31/541;;A61K31/55;;G01N33/6893;;G01N2800/105,A61K31/4155;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/44;;A61K31/47;;A61K31/4725;;A61K31/519;;A61P19/02,,15,13,123-947-125-940-840;;023-821-055-577-433;;084-368-086-008-276;;048-225-408-062-651;;002-700-560-424-865;;070-614-123-913-690;;060-353-899-686-178;;145-411-913-168-583;;083-476-311-918-957;;102-071-695-047-127;;053-522-627-413-564;;012-631-394-353-315;;015-453-357-530-757,10.1146/annurev.cellbio.16.1.191;;11031235;;10.1002/cbf.2852;;22714865;;10.1016/j.cell.2012.05.012;;22682243;;22617420;;10.1038/emboj.2012.146;;pmc3380217;;10.1038/nrg1427;;15372092;;15371327;;10.1101/gad.1230704;;pmc522990;;10.1016/j.bone.2008.12.006;;19136083;;15868625;;10.1021/acs.jmedchem.7b01223.s002;;10.1021/acs.jmedchem.7b01223;;28991472;;6382953;;10.1016/0065-2571(84)90007-4;;10.1016/j.amjmed.2007.04.005;;17976416;;16678413;;10.1016/j.bmcl.2006.04.046;;22491093;;10.1126/science.1215157,"ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, vol. 16, 2000, pages 191 - 220;;CELL BIOCHEMISTRY AND FUNCTION, vol. 30, no. 8, 2012, pages 633 - 642;;CELL, vol. 149, no. 6, 2012, pages 1192 - 1205;;CELL, vol. 127, no. 3, 2006, pages 469 - 80;;THE EMBO JOURNAL, vol. 31, 2012, pages 2670 - 84;;NATURE REVIEWS GENETICS, vol. 5, 2004, pages 691 - 701;;GENES & DEVELOPMENT, vol. 18, no. 19, 2004, pages 2404 - 2417;;BONE, vol. 44, no. 4, 2009, pages 522 - 527;;THE JOURNAL OF RHEUMATOLOGY, vol. 32, no. 5, 2005, pages 876 - 886;;JOURNAL OF MEDICINAL CHEMISTRY, vol. 60, no. 21, 2017, pages 8989 - 9002;;CHOUTALALAY, ADVANCES IN ENZYME REGULATION, vol. 22, 1984, pages 27 - 55;;THE AMERICAN JOURNAL OF MEDICINE, vol. 120, no. 11, 2007, pages 936 - 939;;BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 16, no. 14, 2006, pages 3740 - 3744;;EMBO MOLECULAR MEDICINE, vol. 10, no. 6, 2018, pages e8289;;JOHNSON K.: ""A Stem Cell-Based Approach to Cartilage Repair"", SCIENCE, vol. 336, no. 6082, 2012, pages 717 - 721, XP055454254",PENDING
55,WO,A3,WO 2020/150552 A3,063-107-628-108-902,2020-08-27,2020,US 2020/0013995 W,2020-01-17,US 201962793855 P,2019-01-17,METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK,"Provided herein are methods of treating cartilage disorders in a subject using a dual CLK/DYRK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, or a combination of a CLK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, and DYRK inhibitor or, pharmaceutically acceptable salt or solvate thereof.",SAMUMED LLC;;DESHMUKH VISHAL;;O'GREEN ALYSSA-LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,DESHMUKH VISHAL;;O'GREEN ALYSSA-LAUREN;;BOSSARD CARINE;;BARROGA CHARLENE F;;HOOD JOHN,,https://lens.org/063-107-628-108-902,Search Report,yes,12,0,4,4,0,A61K31/4155;;A61K31/44;;A61K31/47;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/4725;;A61K31/519;;A61P19/02;;Y02A50/30;;A61K31/416;;A61K31/427;;A61K31/437;;A61K31/438;;A61K31/4439;;A61K31/444;;A61K31/496;;A61K31/497;;A61K31/4985;;A61K31/501;;A61K31/5386;;A61K31/541;;A61K31/55;;G01N33/6893;;G01N2800/105,A61K31/4155;;A61K31/416;;A61K31/4162;;A61K31/4184;;A61K31/4188;;A61K31/44;;A61K31/47;;A61K31/4725;;A61K31/519;;A61P19/02,,1,1,130-845-693-448-957,10.1016/j.joca.2017.02.520,"DESHMUKH V ET AL: ""A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee"", OSTEOARTHRITIS AND CARTILAGE, BAILLIERE TINDALL, LONDON, GB, vol. 26, no. 1, 6 September 2017 (2017-09-06), pages 18 - 27, XP085304372, ISSN: 1063-4584, DOI: 10.1016/J.JOCA.2017.08.015",PENDING
56,WO,A1,WO 2012/054861 A1,133-782-352-262-920,2012-04-26,2012,US 2011/0057335 W,2011-10-21,US 40604010 P,2010-10-22,GLP-1 POLYMER CONJUGATES HAVING A RELEASABLE LINKAGE,The present invention provides GLP-1 -polymer conjugates having a releasable linkage. Methods of making conjugates and methods for administering conjugates are also provided.,NEKTAR THERAPEUTICS;;BOSSARD MARY J;;FRY DENNIS G;;LIU XIAOFENG;;ZHANG JOHN;;ROCZNIAK STEVEN O,BOSSARD MARY J;;FRY DENNIS G;;LIU XIAOFENG;;ZHANG JOHN;;ROCZNIAK STEVEN O,,https://lens.org/133-782-352-262-920,Patent Application,yes,24,3,1,1,0,A61K47/60;;C07K14/605,A61K47/48;;C07K14/605,,20,8,017-995-710-508-737;;125-439-449-787-91X;;017-186-458-065-494;;017-186-458-065-494;;029-543-208-437-96X;;092-115-830-262-42X;;028-393-332-651-43X;;005-162-405-484-335,10.1021/bc00022a008;;8218486;;10.1038/nrd1033;;12612647;;15369394;;10.1021/jm0497693;;15369394;;10.1021/jm0497693;;10.1016/0003-2697(80)90492-3;;7435960;;10.1210/endo.133.4.8404634;;10.1210/en.133.4.1907;;8404634;;10.1126/science.279.5347.84;;9417030;;10672909;;10.1016/s0167-0115(99)00095-6,"ZALIPSKY, BIOCONJUG. CHEM., vol. 4, no. 4, 1993, pages 296 - 299;;OUCHI ET AL., DRUG DES. DISCOV., vol. 2, no. 1, 1992, pages 93 - 105;;HARRIS ET AL., NAT. REV. DRUG DISCOV., vol. 2, no. 3, 2003, pages 214 - 22 1;;GREENWALD, EXP. OPIN. THER. PATENTS, vol. 2, no. 6, 1997, pages 601 - 609;;PELEG-SCHULMAN, J. MED. CHEM., vol. 47, 2004, pages 4897 - 4904;;PELEG-SCHULMAN, J NLED. CHEM., vol. 47, 2004, pages 4897 - 4904;;GREENE ET AL.: ""PROTECTIVE GROUPS IN ORGANIC SYNTHESIS"", 1999, JOHN WILEY AND SONS, INC.;;OUCHI ET AL., POLYMER PREPRINTS, vol. 38, no. 1, 1997, pages 582 - 3;;SIMS ET AL., ANAL. BIOCHEM, vol. 107, 1980, pages 60 - 63;;GOKE ET AL., J. BIOT. CHEM., vol. 268, 1993, pages 19650 - 55;;DUGAS H., PENNY, C.: ""Bioorganic Chemistry"", 1981, SPRINGER VERLAG, pages: 54 - 92;;MERRIFIELD, CHEM SOC., vol. 85, 1962, pages 2149;;STEWART, YOUNG: ""Solid Phase Peptide Synthesis"", 1969, FREEMAN, pages: 24 - 66;;DILLON ET AL., ENDOCRINOLOGY, vol. 133, 1993, pages 1907 - 1910;;ZLOKARNIK ET AL., SCIENCE, vol. 279, 1998, pages 84 - 88;;GALLWITZ ET AL., REGULATORY PEPTIDES, vol. 86, no. 1-3, 2000, pages 103 - 111;;""Remington: The Science & Practice of Pharmacy"", 1995, WILLIAMS & WILLIAMS;;""Physician's Desk Reference"", 1998, MEDICAL ECONOMICS;;KIBBE, A.H.: ""Handbook of Pharmaceutical Excipients"", 2000, AMERICAN PHARMACEUTICAL ASSOCIATION;;J. MARCH: ""Advanced Organic Chemistry: Reactions Mechanisms and Structure"", 1992, WILEY-INTERSCIENCE",PENDING
57,WO,A1,WO 2012/054822 A1,049-328-036-586-603,2012-04-26,2012,US 2011/0057267 W,2011-10-21,US 40595110 P,2010-10-22,PHARMACOLOGICALLY ACTIVE POLYMER-GLP-1 CONJUGATES,"The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attached to the water-soluble oligomer.",NEKTAR THERAPEUTICS;;BOSSARD MARY J;;FRY DENNIS G;;LIU XIAOFENG;;ZHANG JOHN;;ROCZNIAK STEVEN O,BOSSARD MARY J;;FRY DENNIS G;;LIU XIAOFENG;;ZHANG JOHN;;ROCZNIAK STEVEN O,,https://lens.org/049-328-036-586-603,Patent Application,yes,41,3,1,1,4,A61K47/60,A61K47/48,,17,9,056-186-849-965-582;;092-115-830-262-42X;;028-393-332-651-43X;;025-930-820-482-18X;;086-488-692-239-268;;056-891-153-615-422;;029-543-208-437-96X;;014-403-050-720-693;;033-968-214-028-407,10.1016/s0021-9258(19)36565-2;;8396143;;10.1210/endo.133.4.8404634;;10.1210/en.133.4.1907;;8404634;;10.1126/science.279.5347.84;;9417030;;12052707;;10.1016/s0169-409x(02)00020-0;;10.1016/0169-409x(95)00023-z;;12052709;;10.1016/s0169-409x(02)00022-4;;10.1016/0003-2697(80)90492-3;;7435960;;15769092;;10.1021/bc049735+;;10.1007/s00125-006-0234-3;;16586064,"GOKE ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 19650 - 55;;DUGAS H., PENNY, C.: ""Bioorganic Chemistry"", 1981, SPRINGER VERLAG, pages: 54 - 92;;MERRIFIELD, CHEM SOC., vol. 85, 1962, pages 2149;;STEWART, YOUNG, SOLID PHASE PEPTIDE SYNTHESIS, 1969, pages 24 - 66;;DILLON ET AL., ENDOCRINOLOGY, vol. 133, 1993, pages 1907 - 1910;;ZLOKARNIK ET AL., SCIENCE, vol. 279, 1998, pages 84 - 88;;""Poly(ethylene glycol), Chemistry and Biological Applications"", 1997, ACS;;""Advanced Drug Delivery Reviews"", vol. 54, 2002, article ""Peptide and Protein PEGylation"", pages: 453 - 609;;ZALIPSKY, S. ET AL.: ""Polyethylene Glycol Chemistry: Biotechnical and Biomedical Applications"", 1992, PLENUS PRESS, article ""Use offunctionalized Poly(Ethylene Glycols) for Modification of Polypeptides"";;ZALIPSKY, ADVANCED DRUG REVIEWS, vol. I6, 1995, pages 157 - 182;;ROBERTS ET AL., ADV. DRUG DELIVERY REVIEWS, vol. 54, 2002, pages 459 - 476;;SIMS ET AL., ANAL. BIOCHEM, vol. 107, 1980, pages 60 - 63;;""Remington: The Science & Practice of Pharmacy"", 2005, WILLIAMS & WILLIAMS;;""Physician's Desk Reference"", 2006, MEDICAL ECONOMICS;;J. MARCH: ""Advanced Organic Chemistry: Reactions Mechanisms and Structure"", 1992, WILEY-INTERSCIENCE;;LEE ET AL., BIOCONJUGATE CHEMISTRY, vol. 16, 2005, pages 377 - 382;;LEE ET AL., DIABETOLOGIA, vol. 49, 2006, pages 1608 - 1611",PENDING
58,WO,A1,WO 2020/013980 A1,084-324-520-473-740,2020-01-16,2020,US 2019/0038691 W,2019-06-24,US 201862695413 P,2018-07-09,ORGANIC-INORGANIC COMPOSITES AND METHODS OF MANUFACTURING THEREOF,"A composite has repeating domains of an inorganic glass and a polymer, such that the inorganic glass and the polymer each have a glass transition temperature (T g ) or softening temperature of less than 450 o C, and at least 50% of the inorganic glass domains have a length of less than 30 µm as measured along at least one cross-sectional dimension.",CORNING INC,DECKER HEATHER BOSSARD;;HART SHANDON DEE;;LI YANFEI;;MCCARTHY JOSEPH EDWARD;;MCENROE DAVID JOHN;;QUESADA MARK ALEJANDRO,,https://lens.org/084-324-520-473-740,Patent Application,yes,5,0,2,2,0,C03C3/19;;C08L81/06;;C03C13/048;;C03C25/32;;B29C70/20;;C03B37/028;;C03B19/02;;B29K2101/12;;B29K2309/08;;B29K2105/124;;C08K5/0058;;B29C70/20;;B29K2079/085;;B29K2081/04;;B29K2081/06;;B29K2309/08;;C03C3/19;;C03C13/00;;C03C2213/00,C03C3/19;;B29C70/20;;C03B17/04;;C03B37/02;;C03C13/04;;C03C25/32;;C08K3/40;;C08L79/08;;C08L81/06,,0,0,,,,PENDING
59,US,A1,US 2022/0016854 A1,057-309-297-863-943,2022-01-20,2022,US 201917258958 A,2019-06-24,US 201917258958 A;;US 201862695413 P;;US 2019/0038691 W,2018-07-09,ORGANIC-INORGANIC COMPOSITES AND METHODS OF MANUFACTURING THEREOF,"A composite has repeating domains of an inorganic glass and a polymer, such that the inorganic glass and the polymer each have a glass transition temperature (T g ) or softening temperature of less than 450° C., and at least 50% of the inorganic glass domains have a length of less than 30 μm as measured along at least one cross-sectional dimension.",CORNING INC,DECKER HEATHER BOSSARD;;HART SHANDON DEE;;LI YANFEI;;MCCARTHY JOSEPH EDWARD;;MCENROE DAVID JOHN;;QUESADA MARK ALEJANDRO,CORNING INCORPORATED (2021-01-06),https://lens.org/057-309-297-863-943,Patent Application,yes,5,0,2,2,0,C03C3/19;;C08L81/06;;C03C13/048;;C03C25/32;;B29C70/20;;C03B37/028;;C03B19/02;;B29K2101/12;;B29K2309/08;;B29K2105/124;;C08K5/0058;;B29C70/20;;B29K2079/085;;B29K2081/04;;B29K2081/06;;B29K2309/08;;C03C3/19;;C03C13/00;;C03C2213/00,B29C70/20;;C03C3/19;;C03C13/00,,2,1,001-505-449-440-680,10.1016/j.jnoncrysol.2010.02.019,"Lim et al., Properties and structures of tin borophosphate glasses, 2010, Journal of Non-Crystalline Solids 356, pgs. 1379-1384;;Table 21.7. Properties of Polysulfones. (Retrieved November 2, 2023 from https://app.knovel.com/hotlink/itble/rcid:kpBPME0001/id:kt00XRETU3/brydsons-plastics-materials/table-21-7-properties)",PENDING
60,US,A1,US 2019/0227002 A1,117-729-395-349-054,2019-07-25,2019,US 201916254804 A,2019-01-23,US 201916254804 A;;US 201862621267 P;;US 201862686880 P,2018-01-24,APPARATUS AND METHODS FOR INSPECTING DAMAGE INTENSITY,"An inspection apparatus including a light source, a sample holding stage, an image capture device, positioned to receive light from the light source after the light has interacted with a sample on the sample holding stage, and a damage metric. The damage metric includes two or more damage levels, and is a function of light in a test image. Further, the damage metric may correlate to visual observation so that an inspection apparatus may mimic how users of devices will perceive damage to the devices. The damage metric may be adjusted to account for different damage types, for example, abrasion and scratch damage.",CORNING INC,BITTNER EVAN JAMES;;BROCKWAY DAVID JOHN;;CECALA CHRISTINE;;DECKER HEATHER BOSSARD;;HART SHANDON DEE;;NULL ERIC LOUIS,CORNING INCORPORATED (2018-12-20),https://lens.org/117-729-395-349-054,Patent Application,yes,9,0,2,2,0,G01N21/8803;;G01N21/8806;;G01N21/892;;G01N21/93;;G01N2021/8854;;G01N21/958;;G01N2201/02;;G01N2201/127;;G01N21/8851;;G01N21/8803;;G01N2021/8854;;G01N21/8806;;G01N21/892;;G01N21/93,G01N21/958;;G01N21/88,,0,0,,,,DISCONTINUED
61,WO,A1,WO 2019/147730 A1,074-281-913-898-352,2019-08-01,2019,US 2019/0014835 W,2019-01-23,US 201862621267 P;;US 201862686880 P,2018-01-24,APPARATUS AND METHODS FOR INSPECTING DAMAGE INTENSITY,"An inspection apparatus including a light source, a sample holding stage, an image capture device, positioned to receive light from the light source after the light has interacted with a sample on the sample holding stage, and a damage metric. The damage metric includes two or more damage levels, and is a function of light in a test image. Further, the damage metric may correlate to visual observation so that an inspection apparatus may mimic how users of devices will perceive damage to the devices. The damage metric may be adjusted to account for different damage types, for example, abrasion and scratch damage.",CORNING INC,BITTNER EVAN JAMES;;BROCKWAY DAVID JOHN;;CECALA CHRISTINE;;DECKER HEATHER BOSSARD;;HART SHANDON DEE;;NULL ERIC LOUIS,,https://lens.org/074-281-913-898-352,Patent Application,yes,8,0,2,2,0,G01N21/8803;;G01N21/8806;;G01N21/892;;G01N21/93;;G01N2021/8854;;G01N21/958;;G01N2201/02;;G01N2201/127;;G01N21/8851;;G01N21/8803;;G01N2021/8854;;G01N21/8806;;G01N21/892;;G01N21/93,G01N21/892;;G01N21/88;;G01N21/93,,0,0,,,,PENDING
62,US,A1,US 2015/0224545 A1,126-292-078-009-31X,2015-08-13,2015,US 201514642826 A,2015-03-10,US 201514642826 A;;US 201313909782 A;;US 67772010 A;;US 2008/0010715 W;;US 96005007 P;;US 7186008 P,2007-09-13,Facility Wide Mixed Mail Sorting and/or Sequencing System and Components and Methods Thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP,BAILEY DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MICHA JAMIE;;OLVER WILLIAM;;RIESS MICHAEL;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;WILLIAMS BRUCE,LOCKHEED MARTIN CORPORATION (2015-04-03),https://lens.org/126-292-078-009-31X,Patent Application,yes,11,7,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52,,0,0,,,,INACTIVE
63,US,B2,US 9758315 B2,179-950-672-300-323,2017-09-12,2017,US 201514642826 A,2015-03-10,US 201514642826 A;;US 201313909782 A;;US 67772010 A;;US 2008/0010715 W;;US 96005007 P;;US 7186008 P,2007-09-13,Facility wide mixed mail sorting and/or sequencing system and components and methods thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP,BAILEY DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MICHA JAMIE;;OLVER WILLIAM;;RIESS MICHAEL;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;WILLIAMS BRUCE,LOCKHEED MARTIN CORPORATION (2015-04-03),https://lens.org/179-950-672-300-323,Granted Patent,yes,33,0,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B65G47/46;;B07C3/00;;B07C5/00;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/52,,4,0,,,"European Office Action for Application No. 08830359.9 dated Aug. 19, 2014; 3 Pages.;;Extended European Search Report for Application No. 08830359.9 dated Jun. 21, 2012.;;Office Action in related U.S. Appl. No. 14/643,705 dated Feb. 7, 2017, 6 pages.;;Notice of Allowance dated May 17, 2017 in related U.S. Appl. No. 14/643,705, 16 pages.",INACTIVE
64,DE,D1,DE 59811884 D1,010-085-254-249-219,2004-10-07,2004,DE 59811884 T,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"Mehrstufiges Verfahren zur Herstellung von (1S,4R)- und/oder (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopenten-1-methanol",,LONZA AG VISP,BERNEGGER DR;;URBAN EVA-MARIA;;BIRCH DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD DR;;BRIEDEN DR;;DUC DR;;GORDON JOHN;;O'MURCHU DR;;GUGGISBERG DR,,https://lens.org/010-085-254-249-219,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C12P41/00;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
65,US,B1,US 6252112 B1,138-243-812-176-61X,2001-06-26,2001,US 37385799 A,1999-08-13,US 37385799 A;;CH 111697 A;;CH 274097 A;;US 7355398 A,1997-05-13,"Process for the preparation of an enantiomer of a (1R, 4S)- or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative","A novel process for the preparation of (1S, 4R)- or (1R, 4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2 -cyclopentene-1-methanol of the formula ##STR1## is described.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KNUT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/138-243-812-176-61X,Granted Patent,yes,4,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,564/217;;435/128;;435/129;;560/115;;564/186;;564/210;;564/216,3,3,007-200-416-148-633;;061-911-991-974-201;;082-533-768-814-738,11667763;;10.1021/jo961241l;;10.1021/jo960708p;;11667311;;10.1021/jo00119a044,"Luis E. Martinez et al., ""Highly Efficient Enantioselective Synthesis of Carbocyclic Nucleoside Analogs Using Selective Early Transition Metal Catalysis,"" J. Org. Chem. 1996 vol. 61, pp. 7963-66.;;Michael T. Crimmins et al., ""An Efficient Asymmetric Approach to Carbocyclic Nucleosides: Asymmetric Synthesis of 1259089, a Potent Inhibitor of HIV Reverse Transcriptase,"" J. Org. Chem. 1996, vol. 61, pp. 4,192-93.;;Jeffrey Campbell et al., ""Chirospecific Synthesis and Precursors of Cyclopentene and Cyclopentene Carbocyclic Nucleosides by [3+3]-Coupling and Transannular Alkylation,"" J. Org. Chem. 1995, vol. 60, pp. 4602-4616.",EXPIRED
66,CZ,B6,CZ 297887 B6,133-488-073-543-538,2007-04-18,2007,CZ 2006694 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,"Process for preparing enantiomer of (1R, 4S)- or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative and (1R, 4S)-N-butyryl-1-amino-4-(hydroxymethyl)-2-cyclopentene enantiomer","In the present invention, there is disclosed a process for preparing enantiomer of (1R, 4S)- or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative of the general formulae XVI, XVII wherein the preparation process is characterized in that in the first stage there is converted cyclopentene derivative of the general formula V to (1R,4S)- or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene of the general formulae VI, VII using a microorganism being able to use cyclopentene derivative of the general formula V as the only source of nitrogen, carbon or carbon and nitrogen by means of N-acetyl-aminoalcohol hydrolase or by means of penicillin G acylase, and in the second stage the (1R,4S)- or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene obtained in the first stage is then acylated to a compound of the general formula XVI or XVII. There is also disclosed (1R,4S)-N-butyryl-1-amino-4-(hydroxymethyl)-2-cyclopentene enantiomer of the general formula XVIII with more than 0 percent of enantiomeric excess.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;OAMURCHU COLM;;GUGGISBERG YVES,,https://lens.org/133-488-073-543-538,Granted Patent,no,2,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C233/23;;C12P41/00;;C07C231/18;;C07C231/20;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
67,SK,A3,SK 58998 A3,106-813-144-785-970,1998-12-02,1998,SK 58998 A,1998-05-04,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PRODUCING (1S,4R)- OR (1R,4S)-4-(2-AMINO-6-CHLORO-9- -H-PURIN-9-YL)-2-CYCLOPENTEN-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA M;;BIRCH OLWEN M;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/106-813-144-785-970,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C12P41/00;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
68,CA,C,CA 2237297 C,185-967-962-756-773,2008-03-11,2008,CA 2237297 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR THE PREPARATION OF (1S,4R)-OR(1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL","A novel process for the preparation of (1S,4R)- or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclo- pentene-1-methanol of the formula: <IMG> is described. This entails in a first stage acylating (~)- 2-azabicyclo[2.2.1]hept-5-en-3-one of the formula: <IMG> to give a (~)-2-azabicyclo[2.2.1]hept-5-en-3-one derivative of the general formula: <IMG> in which R1 denotes C1-4-alkyl, C1-4-alkoxy, aryl or aryloxy, the latter being reduced in a second stage to give a cyclopentene derivative of the general formula: <IMG> in which R1 has the stated meaning. The cyclopentene derivative V is then converted in a third stage biotechnologically into a (1R,4S)- or (1S,4R)-1-amino-4- (hydroxymethyl)-2-cyclopentene of the formula: <IMG> the latter being converted in a fourth stage with N-(2- amino-4,6-dichloro-5-pyrimidinyl)formamide of the formula: <IMG> into a (1S,4R)- or (1R,4S)-4-[(2-amino-6-chloro-5- formamido-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol of the formula: <IMG> Finally, the compound of forumula IX or X is cyclized in a fifth stage in a known manner to form the final product of formula I or II.",LONZA AG,BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;BERNEGGER CHRISTINE;;BOSSARD PIERRE;;BRIEDEN WALTER;;GUGGISBERG YVES;;URBAN EVA MARIA;;DUC LAURENT;;ETTER KAY-SARA;;GORDON JOHN;;O'MURCHU COLM,,https://lens.org/185-967-962-756-773,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P13/00;;C12P41/00;;C07C231/02;;C07C231/18;;C07C231/20;;C07C233/23;;C07C269/06;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
69,US,A,US 6156893 A,005-271-090-283-485,2000-12-05,2000,US 7355398 A,1998-05-06,CH 111697 A;;CH 274097 A,1997-05-13,"Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol","A novel process for the preparation of (1S,4R)- or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclo-pentene-1-methanol of the formulae ##STR1## is described. This entails in the first stage (.+-.)-2-aza-bicyclo[2.2.1]hept-5-en-3-one of the formula ##STR2## being acylated to give a (.+-.)-2-azabicyclo[2.2.1]hept-5-en-3-one derivative of the general formula ##STR3## in which R.sup.1 denotes C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl or aryloxy, the latter being reduced in the second stage to give a cyclopentene derivative of the general formula ##STR4## in which R.sup.1 has the stated meaning, the latter then being converted in the third stage biotechnologically into the (1R,4S)- or (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene of the formula ##STR5## the latter being converted in the fourth stage with N-(2-amino-4,6-dichloro-5-pyrimidinyl)formamide of the formula ##STR6## into the (1S,4R)- or (1R,4S)-4-[(2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino]-2-cyclopente ne-1-methanol of the formulae ##STR7## and the latter being cyclized in the fifth stage in a known manner to the final product of the formula I or II.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,LONZA AG (1998-08-12),https://lens.org/005-271-090-283-485,Granted Patent,yes,5,10,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C12P41/00;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,544/277;;560/126;;564/142;;564/143,5,4,141-459-482-255-411;;007-200-416-148-633;;061-911-991-974-201;;082-533-768-814-738,10.1080/07328319608002411;;11667763;;10.1021/jo961241l;;10.1021/jo960708p;;11667311;;10.1021/jo00119a044,"Katagiri, Nucleosides & Nucleotides 15(1 3) 631 647, 1996.;;Text version of USP 5270315, Dec. 1993.;;Luis E. Martinez et al., Highly Efficient and Enantioselective Synthesis of Carbocyclic Nucleoside Analogs Using Selective Early Transition Metal Catalysis , J. Org. Chem. 1996, vol. 61, pp. 7963 7966.;;Michael T. Crimmins et al., An Efficient Asymmetric Approach to Carbocyclic Nucleosides: Asymmetric Synthesis of 1259U89, a Potent Inhibitor of HIV Reverse Transcriptase , J. Org. Chem 1996, vol. 61, pp. 4192 4193.;;Jeffrey A. Campbell et al., Chirospecific Syntheses and Precursors of Cyclopentane and Cyclopentene Carbocyclic Nucleosides by 3 3 Coupling and Transannular Alkyalation , J. Org. Chem. 1995, vol. 60, pp. 4602 4616.",EXPIRED
70,CA,A1,CA 2237297 A1,142-084-541-899-718,1998-11-13,1998,CA 2237297 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR THE PREPARATION OF (1S,4R)-OR(1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL","A novel process for the preparation of (1S,4R)- or (1S,4R)- or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclo-pentene-1-methanol of the formula: <see fig. I> or <see fig. II> is described. This entails in a first stage acylating (~)-2-azabicyclo¢2.2.1!hept-5-en-3-one of the formula: <see fig. III> to give a (~)-2-azabicyclo¢2.2.1!hept-5-en-3-one derivative of the general formula: <see fig. IV> in which R1 denotes C1-4-alkyl, C1-4-alkoxy, aryl or aryloxy, the latter being reduced in a second stage to give a cyclopentene derivative of the general formula: <see fig. V> in which R1 has the stated meaning. The cyclopentene derivative V is then converted in a third stage biotechnologically into a (1R,4S)- or (1S,4R)-1-amino-4- (hydroxymethyl)-2-cyclopentene of the formula: <see fig. VI> or <see fig. VII> the latter being converted in a fourth stage with N-(2-amino-4,6-dichloro-5-pyrimidinyl)formamide of the formula: <see fig. VIII> into a (1S,4R)- or (1R,4S)-4-¢(2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino!-2-cyclopentene-1-methanol of the formula: <see fig. IX> or <see fig. X> Finally, the compound of forumula IX or X is cyclized in a fifth stage in a known manner to form the final product of formula I or II.",LONZA AG,BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;URBAN EVA MARIA;;GORDON JOHN;;ETTER KAY-SARA;;BERNEGGER CHRISTINE;;O'MURCHU COLM;;BIRCH OLWEN MARY;;BRUX FRANK;;BURGDORF KURT;;GUGGISBERG YVES,,https://lens.org/142-084-541-899-718,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
71,PL,B1,PL 197848 B1,142-177-618-920-865,2008-05-30,2008,PL 32626798 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"Method of obtaining (1S,4R)- or (1R,4S)-4(2-amino-6-chloro-9H-purinyl-9)-cyclopentene-1-methanol",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/142-177-618-920-865,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07D473/32;;C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
72,US,B1,US 6262295 B1,185-116-582-806-008,2001-07-17,2001,US 37385699 A,1999-08-13,US 37385699 A;;CH 111697 A;;CH 274097 A;;US 7355398 A,1997-05-13,Process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative,"A process for the preparation of a racemic or optically active compound of the formula ##STR1## where the group R.sup.1 is an unsubstituted or a halogen substituted C.sub.1-4 -alkyl, a C.sub.1-4 -alkoxy, an aryl, an arylalkyl, an aryloxy, or arylalkylloxy.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/185-116-582-806-008,Granted Patent,yes,4,2,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,560/115;;564/217;;564/142;;564/143,3,3,007-200-416-148-633;;061-911-991-974-201;;082-533-768-814-738,11667763;;10.1021/jo961241l;;10.1021/jo960708p;;11667311;;10.1021/jo00119a044,"Luis E. Martinez et al., ""Highly Efficient Enantioselective Synthesis of Carbocyclic Nucleoside Analogs Using Selective Early Transition Metal Catalysis,"" J. Org. Chem. 1996 vol. 61, pp. 7963-7966.;;Michael T. Crimmins et al., ""An Efficient Asymmetric Approach to Carbocyclic Nucleosides: Asymmetric Synthesis of 1259089, a Potent Inhibitor of HIV Reverse Transcriptase,"" J. Org. Chem. 1996, vol. 61, pp. 4,192-4,193.;;Jeffrey Campbell et al., ""Chirospecific Synthesis and Precursors of Cyclopentene and Cyclopentene Carbocyclic Nucleosides by [3+3]-Coupling and Transannular Alkylation,"" J. Org. Chem. 1995, vol. 60, pp. 4602-4616.",EXPIRED
73,US,A,US 6137007 A,010-370-918-382-534,2000-10-24,2000,US 37386299 A,1999-08-13,US 37386299 A;;CH 111697 A;;CH 274097 A;;US 7355398 A,1997-05-13,"Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene","A novel process for the preparation of (1S,4R)- or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol of the formulae ##STR1## is described. This entails in the first stage (.+-.)-2-azabicyclo[2.2.1]hept-5-en-3-one of the formula ##STR2## being acylated to give a (.+-.)-2-azabicyclo[2.2.1]hept-5-en-3-one derivative of the general formula ##STR3## in which R.sup.1 denotes C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl or aryloxy, the latter being reduced in the second stage to give a cyclopentene derivative of the general formula ##STR4## in which R.sup.1 has the stated meaning, the latter then being converted in the third stage biotechnologically into the (1R,4S)- or (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene of the formula ##STR5## the latter being converted in the fourth stage with N-(2-amino-4,6-dichloro-5-pyrimidinyl)formamide of the formula ##STR6## into the (1S,4R)- or (1R,4S)-4-[(2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino]-2-cyclopente ne-1-methanol of the formulae ##STR7## and the latter being cyclized in the fifth stage in a known manner to the final product of the formula I or II.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KNUT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/010-370-918-382-534,Granted Patent,yes,3,3,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,564/217,3,3,007-200-416-148-633;;061-911-991-974-201;;082-533-768-814-738,11667763;;10.1021/jo961241l;;10.1021/jo960708p;;11667311;;10.1021/jo00119a044,"Luis E. Martinez et al., Highly Efficient Enantioselective Synthesis of Carbocyclic Nucleoside Analogs Using Selective Early Transition Metal Catalysis, J. Org. Chem. 1996 vol. 61, pp. 7963 7966.;;Michael T. Crimmins et al., An Efficient Asymmetric Approach to Carbocyclic Nucleosides: Assymmetric Synthesis of 1259089, a Potent Inhibitor of HIV Reverse Transcriptase, J. Org. Chem. 1996, vol. 61, pp. 4,192 93.;;Jeffrey Campbell et al., Chirospecific Synthesis and Precursors of Cyclopentene and Cylopentene Carbocyclic Nucleosides by 3 3 Coupling and Transannular Alkylation, J. Org. Chem. 1995, vol. 60, pp. 4602 4616.",EXPIRED
74,KR,B1,KR 100601764 B1,160-776-870-181-723,2006-07-19,2006,KR 20050098642 A,2005-10-19,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR THE PREPARATION OF (1S,4R)- OR (1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/160-776-870-181-723,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/12;;C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,INACTIVE
75,NO,L,NO 982149 L,062-798-423-210-435,1998-11-16,1998,NO 982149 A,1998-05-12,CH 111697 A;;CH 274097 A,1997-05-13,"FremgangsmÕte for fremstilling av (1S,4R)- eller (1R,4S)-4-(2-amino-6-klor-9H-pyrin-9-yl)-2-cyklopenten-1-metanol",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/062-798-423-210-435,Abstract,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C12P41/00;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
76,NO,B1,NO 324679 B1,119-698-971-832-241,2007-12-03,2007,NO 982149 A,1998-05-12,CH 111697 A;;CH 274097 A,1997-05-13,"(1S,4R)- eller (1R,4S)-4-(2-amino-6-klor-9H-pyrin-9-yl)-2-cyklopenten-1-metanol og fremgangsmate for fremstilling av slike.",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/119-698-971-832-241,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/11;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
77,CZ,B6,CZ 297894 B6,193-655-475-391-452,2007-04-25,2007,CZ 145898 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,"Process for preparing (1S,4R)- or (1R,4S)-4-(2-amino-6-chloro-9-h-purin-9-yl)-2-cyclopentene-1-methanol","In the present invention, there is disclosed a process for preparing (1S,4R)- and/or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol of the general formulae I and II respectively or their salts comprising: (i) acylating (plus or minus)-2-azabicyclo (2.2.1) hept-5-en-3-one of the general formula III to obtain (plus or minus)-2-azabicyclo (2.2.1) hept-5-en-3-one derivative of the general formula IV; (ii) reducing the obtained derivative of the general formula IV to a 1-amino-4-(hydroxymethyl)-2-cyclopentene derivative of the general formula V; (iii) converting the derivative of the general formula V into (1R,4S)- or (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene of the general formulae VI or VII respectively, using a biotechnological process; (iv) converting the compound obtained in the previous step by N-(2-amino-4,6-dichloropyrimidin-5-yl)-formamide of the general formula VIII to (1S,4R)- or (1R,4S)-4-[(2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino]-2-cyclo-pentene-1-methanol of the general formulae IX or X and (v) cyclising the obtained (1S,4R)- or (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclo pentene-1-methanol to the final product of the general formulae I or II.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;OAMURCHU COLM;;GUGGISBERG YVES,,https://lens.org/193-655-475-391-452,Granted Patent,no,3,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07D239/70;;C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
78,PL,A1,PL 326267 A1,030-013-654-608-877,1998-11-23,1998,PL 32626798 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"METHOD OF OBTAINING (1S,4R)- OR (1R,4S)-4(2-AMINO-6-CHLORO-9H-PURINYL-9)-CYCLOPENTENE-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/030-013-654-608-877,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
79,PL,B1,PL 197831 B1,173-275-735-221-83X,2008-04-30,2008,PL 37694698 A,1998-05-13,CH 111697 A,1997-05-13,Process for preparing racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative,,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/173-275-735-221-83X,Granted Patent,no,0,0,3,47,0,,C12P13/02;;C07C231/18;;C07C233/23;;C07D473/32;;C12P17/18,,0,0,,,,EXPIRED
80,HU,A2,HU P9801083 A2,079-457-339-625-875,1999-11-29,1999,HU P9801083 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PRODUCING (15,4R)- OR (1R,4S)-4-[(2-AMINO-6-CHLORO-9H-PURIN)-9-YL]-2-CYCLOPENTENE-1-METHANOL","A találmány tárgyát eljárás képezi az (I) vagy (II) képletű (1S,4R)-vagy (1R,4S)-4-(2-aminő-6-klór-9H-pűrin-9-il)-2-ciklőpentén-1-metanőlelőállítására. Ezen vegyületeket őly módőn állítják elő, hőgy (+)-2-azabiciklő[2.2.1]hept-5-én-3-őnt (IV) általánős képletű (+)-2-azabiciklő[2.2.1]-hept-5-én-3-őn-származékká acilezik, ahől aképletben R1 jelentése 1-4 szénatőmős alkil-, 1-4 szénatőmős alkőxi-,aril- vagy aril-őxi-csőpőrt; - majd a kapőtt vegyületet (V) általánősképletű ciklőpenténszármazékká redűkálják; - majd a kapőttvegyületeket egy N-acetilaminő-alkőhől-hidrőláz hatású enzimmikrőőrganizműsának segítségével vagy egy penicillin G-acilázsegítségével (VI) vagy (VII) képletű vegyületté alakítják; - majd akapőtt vegyületetet N-(2-aminő-4,6-diklór-pirimidin)-5-il-főrmamiddal(1S,4R)- vagy (1R,4S)-4-[(2-aminő-6-klór-5-főrmamidő-4-pirimidinil)-aminő]-2-ciklőpentén-1-metanőllá alakítják; - majd az így kapőttvegyületeket (I) vagy (II) képletű vegyületekké ciklizálják. Atalálmány szerinti eljárással kapőtt vegyületek közbenső termékként 2-aminő-pűrin-nűkleőzidők előállításáhőz alkalmazhatók. ŕ",LONZA AG,BERNEGGER CHRISTINE;;BIRCH OLWEN MARY;;BOSSARD PIERRE;;BRIEDEN WALTER;;BRUX FRANK;;BURGDORF KURT;;DUC LAURENT;;ETTER KAY-SARA;;GORDON JOHN;;GUGGISBERG YVES;;O'MURCHU COLM;;URBAN EVA MARIA,,https://lens.org/079-457-339-625-875,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C12P41/00;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
81,DK,T3,DK 0878548 T3,129-266-920-595-69X,2004-12-06,2004,DK 98108721 T,1998-05-13,EP 98108721 A;;CH 111697 A;;CH 274097 A,1997-05-13,"Flertrinsfremgangsmåde til fremstilling af (1S,4R)- og/eller (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyclopenten-1-methanol",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA-MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/129-266-920-595-69X,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C12P41/00;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
82,NO,D0,NO 982149 D0,069-660-735-532-241,1998-05-12,1998,NO 982149 A,1998-05-12,CH 111697 A;;CH 274097 A,1997-05-13,"FremgangsmÕte for fremstilling av (1S,4R)- eller (1R,4S)-4-(2-amino-6-klor-9H-pyrin-9-yl)",,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/069-660-735-532-241,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
83,HU,D0,HU 9801083 D0,110-833-380-729-535,1998-07-28,1998,HU P9801083 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PRODUCING (15,4R)- OR (1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTHENE-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE;;BIRCH OLWEN MARY;;BOSSARD PIERRE;;BRIEDEN WALTER;;BRUX FRANK;;BURGDORF KURT;;DUC LAURENT;;ETTER KAY-SARA;;GORDON JOHN;;GUGGISBERG YVES;;O'MURCHU COLM;;URBAN EVA MARIA,,https://lens.org/110-833-380-729-535,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
84,CZ,B6,CZ 297888 B6,129-660-979-671-605,2007-04-18,2007,CZ 2006695 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,Process for preparing racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative,"In the present invention, there is disclosed a process for preparing racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative of the general formula wherein the preparation process comprises acylating a cyclopentene-4-carboxylic acid of the general formula XIV in the form of a racemate or one optically active isomer thereof with a halide of the carboxylic acid of the general formula XI to a racemic or optically active derivative of the cyclopentene-4-carboxylic acid of the general formula XV, in a first preparation stage, while in the second preparation stage said derivative obtained in the first stage is then reduced to a required product of the general formula XIII.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;OAMURCHU COLM;;GUGGISBERG YVES,,https://lens.org/129-660-979-671-605,Granted Patent,no,2,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C233/23;;C12P41/00;;C07C231/18;;C07C231/20;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
85,SK,B6,SK 285229 B6,156-646-581-445-77X,2006-09-07,2006,SK 542005 A,1998-05-04,CH 111697 A;;CH 274097 A,1997-05-13,"Process for the preparation of a (1R, 4S)- or (1S, 4R)-1-amino-4- (hydroxymethyl)-2-cyclopentene derivative and an enantiomer of a (1R,4S)-N-butyryl-1-amino-4-(hydroxymethyl)-2-cyclopenten","The present invention relates to a process for the preparation of an enantiomer of a (1R, 4S)- or (1S, 4R)-1-amino- 4-(hydroxymethyl)-2-cyclopentene derivative of the general formulae (I) and (II), wherein R1 is a C1-4-alkyl, a C1-4-alkoxy, an aryl, or an aryloxy at which in the first stage a 1-amino-4-(hydroxymethyl)-2-cyclopentene derivative of the general formula (IV), wherein R1 is a C1-4-alkyl, an aryl, or an aryloxy is converted using a microorganism which is able to utilize a cyclopeptide derivative of the general formula (IV) as sole nitrogen source, as sole carbon source or as sole carbon and nitrogen source, an enzyme having N-acetylamino-alcohol hydrolase activity or a penicillin G acylase into the (1R, 4S)- or (1S, 4R)-1-amino-4-(hyroxymethyl)-2-cyclopentene of the general formula (V) or (VI) and the latter is then acylated in the second stage to give the compounds of the formula (I) or (II). Enantiomer of (1R, 4S)-N-butyryl-1-amino-4-(hydroxymethyl)-2- cyclopentene of the formula (III).",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O' MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/156-646-581-445-77X,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P13/00;;C07C231/00;;C12P41/00;;C07C231/18;;C07C231/20;;C07C233/00;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
86,SK,B6,SK 284810 B6,172-011-081-190-337,2005-12-01,2005,SK 58998 A,1998-05-04,CH 111697 A;;CH 274097 A,1997-05-13,"Process for the preparation of (1S,4R)- or (1R,4S)-4-(2-amino-6- chloro-9H-purin-9-yl)-2-cyclo-pentene-1-methanol","Process for the preparation of (1S,4R)- or (1R,4S)-4-(2- amino-6-chloro-9H-purin-9-yl)-2-cyclo-pentene-1-methanol of the formulae (I) and (II) is described. This entails in the first stage (+/-)-2-aza-bicyclo[2.2.1]hept-5-en-3-one of the formula (III) being acylated to give a (+/-)-2-azabicyclo[2.2.1]hept-5- en-3-one derivative of the general formula (IV) in which R1 denotes -(C1-C4)alkyl, -(C1-C4)alkoxy, aryl or aryloxy, the latter being reduced in the second stage to give a cyclopentene derivative of the general formula (V) in which R1 has the stated meaning, the latter then being converted in the third stage biotechnologically into the (1R,4S)- or (1S,4R)-1-amino-4- (hydroxymethyl)-2-cyclopentene of the formula (VI, VII) the latter being converted in the fourth stage with N-(2-amino-4,6- dichloro-5-pyrimidinyl)formamide of the formula (VIII) into the (1S,4R)- or (1R,4S)-4-[(2-amino-6-chloro-5-formamido-4- pyrimidinyl)amino]-2-cyclopentene-1-methanol of the formulae (IX, X) and the latter being cyclized in the fifth stage in a known manner to the final product of the formula (I) or (II).",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O' MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/172-011-081-190-337,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C12P41/00;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
87,SK,B6,SK 285228 B6,114-377-495-584-013,2006-09-07,2006,SK 532005 A,1998-05-04,CH 111697 A;;CH 274097 A,1997-05-13,Process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative and racemic N-butyryl-1-amino-4-(hydroxymethyl)-2-cyclopentene,"The present invention relates to a process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2- cyclopentene derivative of the formula (I) in which the group R1 is a C1-4-alkyl, a C1-4-alkoxy, an aryl, or an aryloxy at which in the first stage a cyclopentene-4-carboxylic acid of the formula (II) in the form of the racemate or one of its optically active isomers, is acylated with a carbonyl halide of the general formula (III) in which the group R1 is a C1-4-alkyl, a C1-4-alkoxy, an aryl, or an aryloxy and in which X is a halogen, which is selected from the group consisting of F, Cl, Br, or I, to give a racemic or optically active cyclopentene-4- carboxylic acid derivatives of the general formula (IV) and the latter is reduced in the second stage to give the required product of the formula (I). Enantiomer of (1R, 4S)-N-butyryl-1- amino-4-(hydroxymethyl)-2-cyclopentene.",LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT;;GORDON JOHN;;O' MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/114-377-495-584-013,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/00;;C07C231/18;;C12P41/00;;C07C231/20;;C07C233/00;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
88,HK,A1,HK 1092782 A1,143-379-385-613-240,2007-02-16,2007,HK 06113474 A,2006-12-07,CH 111697 A;;CH 274097 A,1997-05-13,PROCESS FOR PREPARING RACIMATIC OF OPTICALLY ACTIVE 4-(HYDROXYMETHYL)-2- CYCLOPENTENE DERIVATIVE,,LONZA AG,BERNEGGER CHRISTINE;;URBAN EVA MARIA;;BIRCH OLWEN MARY;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE;;BRIEDEN WALTER;;DUC LAURENT L;;GORDON JOHN J;;O'MURCHU COLM;;GUGGISBERG YVES,,https://lens.org/143-379-385-613-240,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C/;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,DISCONTINUED
89,PT,E,PT 878548 E,092-259-925-437-491,2005-01-31,2005,PT 98108721 T,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESSO DE VARIAS ETAPAS PARA A PRODUCAO DE (1S,4R)- E/OU (1R.4S)-4-(2-AMINO-6-CLORO-9-H-PURIN-9-IL)-2-CICLOPENTEN-1-METANOL",,LONZA AG,BRIEDEN WALTER;;BERNEGGER CHRISTINE;;BRUX FRANK;;ETTER KAY-SARA;;GUGGISBERG YVES;;URBAN EVA MARIA;;BIRCH OLWEN MARY DR;;KURT BURGDORF;;BOSSARD PIERRE DR;;DUC LAURENT DR;;JOHN GORDON;;O MURCHU COLM DR,,https://lens.org/092-259-925-437-491,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C12P41/00;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
90,JP,A,JP 2010116397 A,173-190-046-839-359,2010-05-27,2010,JP 2009256398 A,2009-11-09,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PREPARING (1S, 4R)- OR (1R, 4S)-4-(2-AMINO-6-CHLORO-9H-PURINE-9-YL)-2-CYCLOPENTENE-1-METHANOL","<P>PROBLEM TO BE SOLVED: To provide a process for preparing an enantiomer of a cyclopentene derivative of formula XVI or XVII (wherein R1 is 1-4C alkyl, 1-4C alkoxy, aryl, or aryloxy), which is an intermediate for synthesizing (1S, 4R)- or (1R, 4S)-4-(2-amino-6-chloro-9H-purine-9-yl)-2-cyclopentene-1-methanol easily at a low cost and economically. <P>SOLUTION: In the process for preparing an enantiomer of a cyclopentene derivative, the cyclopentene derivative is converted into (1S, 4R)- or (1R, 4S)-1-amino-4-(hydroxymethyl)-2-cyclopentene by using a microorganism capable of utilizing a racemic cyclopentene derivative as a sole nitrogen source and/or a sole carbon source or by using an enzyme having N-acetylamino alcohol hydrolase activity or the like, and then is cyclized. <P>COPYRIGHT: (C)2010,JPO&INPIT",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/173-190-046-839-359,Patent Application,no,3,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/02;;C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C269/04;;C07C271/16;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/16;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,PENDING
91,HU,B1,HU 226327 B1,029-398-107-421-637,2008-08-28,2008,HU P9801083 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PRODUCING (1S,4R)- OR (1R,4S)-4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/029-398-107-421-637,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07D473/40;;C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C12P13/00;;C12P13/02;;C12P17/12;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
92,AT,T1,AT E275206 T1,138-118-904-044-291,2004-09-15,2004,AT 98108721 T,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"MEHRSTUFIGES VERFAHREN ZUR HERSTELLUNG VON (1S, 4R)- UND/ODER (1R,4S)-4-(2-AMINO-6-CHLOR-9-H- PURIN-9-YL)-2-CYCLOPENTEN-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/138-118-904-044-291,Granted Patent,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
93,JP,A,JP 2010106025 A,022-235-320-744-434,2010-05-13,2010,JP 2009256399 A,2009-11-09,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PREPARATION OF (1S, 4R)-OR (1R, 4S)-4-(2-AMINO-6-CHLORO-9H-PURINE-9-YL)-2-CYCLOPENTENE-1-METHANOL","<P>PROBLEM TO BE SOLVED: To provide a process for preparation of a 4-(hydroxymethyl)-2-cyclopentene derivative useful for a medicinal intermediate. <P>SOLUTION: The process for preparation of a 4-(hydroxymethyl)-2-cyclopentene derivative (XIII) represented by formula XIII includes the first stage wherein one of a racemic substance or an optically active isomer of 4-amino-2-cyclopentene carboxylic acid is acylated with a carboxylic acid halide to prepare a 4-acylamino-2-cyclopentene carboxylic acid derivative and the second stage wherein the acylamino-2-cyclopentene carboxylic acid derivative is reduced. In the formula, R<SP>1</SP>is 1-4C alkyl, etc. <P>COPYRIGHT: (C)2010,JPO&INPIT",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/022-235-320-744-434,Patent Application,no,1,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07B53/00;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/32;;C07D473/40;;C12N1/20;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,1,0,,,"JPN6012039209; Ｊｏｕｒｎａｌ ｏｆ Ｏｒｇａｎｉｃ Ｃｈｅｍｉｓｔｒｙ ４３（１２）, 1978, ２３１１-２０",PENDING
94,EP,A3,EP 0878548 A3,124-222-373-053-624,1999-10-13,1999,EP 98108721 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol","Beschrieben wird ein neues Verfahren zur Herstellung von (1S,4R)- oder (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyclopenten-1-methanol der Formeln
  Dabei wird in der ersten Stufe (±)-2-Azabicyclo[2.2.1]hept-5-en-3-on der Formel
   zu einem (±)-2-Azabicyclo[2.2.1]hept-5-en-3-on-derivat der allgemeinen Formel
   worin R 1  C 1-4 -Alkyl, C 1-4 -Alkoxy, Aryl oder Aryloxy bedeutet, acyliert, dieses in der zweiten Stufe zu einem Cyclopentenderivat der allgemeinen Formel
   worin R 1  die genannte Bedeutung hat, reduziert, dieses dann in der dritten Stufe biotechnologisch in das (1R,4S)- oder (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopenten gemäss der Formel   umsetzt, dieses in der vierten Stufe mit N-(2-amino-4,6-dichlorpyrimidin)-5-yl)formamid der Formel
   ins (1S,4R)- oder (1R,4S)-4-[(2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino]-2-cyclopenten-1-methanol der Formeln
   überführt und letzteres in der fünften Stufe aufbekannte Weise zum Endprodukt gemäss Formel I oder II cyclisiert.",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,LONZA AG (2001-09-19),https://lens.org/124-222-373-053-624,Search Report,yes,6,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12P41/00;;C12R1/38,,5,4,054-708-668-064-171;;091-491-064-324-654;;010-356-461-521-74X;;082-533-768-814-738,10.1021/jm00163a004;;2296018;;10.1016/s0957-4166(00)80218-9;;10.1002/hlca.19940770506;;10.1021/jo00119a044,"VINCE, R. AND HUA, M.: ""Synthesis and Anti-HIV Activity of Carbocyclic 2',3'-Didehydro-2',3'-dideoxy 2,6-Disubstituted Purine Nucleosides."", J. MED. CHEM., vol. 33, no. 1, 1990, pages 17 - 21, XP002109188;;TAYLOR, S.J.C. ET AL.: ""Development of the Biocatalytic Resolution of 2-azabicyclo[2.2.1]hept-5-en-3-one as an entry to Single-Enantiomer Carbocyclic Nucleosides."", TETRAHEDRON: ASYMMETRY, vol. 4, no. 6, 1993, pages 1117 - 1128, XP002041316;;HILDEBRAND, S. ET AL.: ""A Short Synthesis of (-)-Carbovir."", HELV. CHIM. ACTA, vol. 77, no. 5, 1994, pages 1236 - 1240, XP002109189;;CAMPBELL J. A. ET AL.: ""Chirospecific Synthesis of Precursors of Cyclopentane and Cyclopentene Carbocyclic Nuceosides by [3+3]-Coupling and Transannular Alkylation."", J. ORG. CHEM., vol. 60, 1995, pages 4602 - 4616, XP002041314;;CHEMICAL ABSTRACTS, vol. 107, no. 5, 3 August 1987, Columbus, Ohio, US; abstract no. 39244, ALLAN, ROBIN D. ET AL: "".gamma.-Aminobutyric acid. Synthesis of analogs of GABA. XV. Preparation and resolution of some potent cyclopentene and cyclopentane derivatives"" XP002113019",EXPIRED
95,US,B2,US 9020634 B2,108-849-343-780-31X,2015-04-28,2015,US 201313909782 A,2013-06-04,US 201313909782 A;;US 67772010 A;;US 2008/0010715 W;;US 96005007 P;;US 7186008 P,2007-09-13,Facility wide mixed mail sorting and/or sequencing system and components and methods thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MARKS KENNETH;;MICHA JAMIE;;NASAKAITIS JOHN;;OLVER WILLIAM;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;SCRIVENER LESLIE;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLIAMS BRUCE;;ZIMMER KEVIN,LOCKHEED MARTIN CORPORATION (2013-08-14),https://lens.org/108-849-343-780-31X,Granted Patent,yes,18,32,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C3/00;;B07C5/00,700/224;;209/584;;209/900;;271/2,2,0,,,"Extended European Search Report for Application No. 08830359.9 dated Jun. 21, 2012.;;European Office Action for Application No. 08830359.9 dated Aug. 19, 2014; 3 Pages.",INACTIVE
96,EP,A2,EP 0878548 A2,080-921-264-689-47X,1998-11-18,1998,EP 98108721 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol","Beschrieben wird ein neues Verfahren zur Herstellung von (1S,4R)- oder (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyclopenten-1-methanol der Formeln
  Dabei wird in der ersten Stufe (±)-2-Azabicyclo[2.2.1]hept-5-en-3-on der Formel
   zu einem (±)-2-Azabicyclo[2.2.1]hept-5-en-3-on-derivat der allgemeinen Formel
   worin R 1  C 1-4 -Alkyl, C 1-4 -Alkoxy, Aryl oder Aryloxy bedeutet, acyliert, dieses in der zweiten Stufe zu einem Cyclopentenderivat der allgemeinen Formel
   worin R 1  die genannte Bedeutung hat, reduziert, dieses dann in der dritten Stufe biotechnologisch in das (1R,4S)- oder (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopenten gemäss der Formel
   umsetzt, dieses in der vierten Stufe mit N-(2-amino-4,6-dichlorpyrimidin)-5-yl)formamid der Formel
   ins (1S,4R)- oder (1R,4S)-4-[(2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino]-2-cyclopenten-1-methanol der Formeln
   überführt und letzteres in der fünften Stufe aufbekannte Weise zum Endprodukt gemäss Formel I oder II cyclisiert.",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,LONZA AG (2001-09-19),https://lens.org/080-921-264-689-47X,Patent Application,yes,0,7,44,47,1,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12P41/00;;C12R1/38,,0,0,,,,EXPIRED
97,EP,B1,EP 0878548 B1,033-662-313-476-860,2004-09-01,2004,EP 98108721 A,1998-05-13,CH 111697 A;;CH 274097 A,1997-05-13,"Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol",,LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,LONZA AG (2001-09-19),https://lens.org/033-662-313-476-860,Granted Patent,yes,6,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12P41/00;;C12R1/38,,5,0,,,"VINCE, R. AND HUA, M.: ""Synthesis and Anti-HIV Activity of Carbocyclic 2',3'-Didehydro-2',3'-dideoxy 2,6-Disubstituted Purine Nucleosides."" J. MED. CHEM., Bd. 33, Nr. 1, 1990, Seiten 17-21, XP002109188;;TAYLOR, S.J.C. ET AL.: ""Development of the Biocatalytic Resolution of 2-azabicyclo[2.2.1]hept-5-en-3-one as an entry to Single-Enantiomer Carbocyclic Nucleosides."" TETRAHEDRON: ASYMMETRY, Bd. 4, Nr. 6, 1993, Seiten 1117-1128, XP002041316;;HILDEBRAND, S. ET AL.: ""A Short Synthesis of (-)-Carbovir."" HELV. CHIM. ACTA, Bd. 77, Nr. 5, 1994, Seiten 1236-1240, XP002109189;;CAMPBELL J. A. ET AL.: ""Chirospecific Synthesis of Precursors of Cyclopentane and Cyclopentene Carbocyclic Nuceosides by [3+3]-Coupling and Transannular Alkylation."" J. ORG. CHEM., Bd. 60, 1995, Seiten 4602-4616, XP002041314;;CHEMICAL ABSTRACTS, vol. 107, no. 5, 3. August 1987 (1987-08-03) Columbus, Ohio, US; abstract no. 39244, ALLAN, ROBIN D. ET AL: "".gamma.-Aminobutyric acid. Synthesis of analogs of GABA. XV. Preparation and resolution of some potent cyclopentene and cyclopentane derivatives"" XP002113019 & AUST. J. CHEM. (1986), 39(6), 855-64 ,",EXPIRED
98,JP,A,JP H115793 A,114-559-087-453-476,1999-01-12,1999,JP 12933898 A,1998-05-12,CH 111697 A;;CH 274097 A,1997-05-13,"PRODUCTION OF (1S,4R)-OR(1R,4S)-4-(2-AMINO-6-CHLORO9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL","PROBLEM TO BE SOLVED: To produce the subject compound useful as an intermediate, etc., for producing a 2-aminopurine nucleoside at a low cost by acylating 2- azabicyclo-hept-5-en-3-ones, reducing the resultant compounds and then reacting the obtained product with a specific microorganism, etc. SOLUTION: A (±)-2-azabicyclo[2.2.1]hept-5-en-3-one represented by formula I is acylated to provide an N-acylated derivative represented by formula II (R<1> is a 1-4C alkyl, a 1-4C alkoxy, an aryl or an aryloxy), which is then reduced to afford a cyclopentene derivative represented by formula III. The resultant cyclopentene derivative represented by formula III is subsequently reacted with a microorganism capable of assimilating the compound as only one nitrogen source, as only one carbon source or as the only one nitrogen source and the only one carbon source or an Nacetylaminoalcohol hydrolase, etc., to provide an optically active amino derivative, which is then reacted with an N-(2- amino-4,6dichloro-5-pyridinyl)formamide represented by formula IV and further cyclized to thereby afford the objective compound represented by formula V.",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/114-559-087-453-476,Patent Application,no,2,1,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12P41/00;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
99,EP,A1,EP 1502914 A1,178-166-401-045-978,2005-02-02,2005,EP 04020273 A,1998-05-13,CH 111697 A;;CH 274097 A;;EP 98108721 A,1997-05-13,Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives,"Beschrieben wird ein Verfahren zur Herstellung eines racemischen oder optisch aktiven 4-(Hydroxymethyl)-2-cyclopentenderivats der allgemeinen Formel
   worin R 1  C 1-4 -Alkyl, C 1-4 -Alkoxy, Aryl oder Aryloxy bedeutet. Bei diesem Verfahren wird ein Cyclopenten-4-carbonsäure der Formel
   in Form des Racemats oder eines seiner optisch aktiven Isomeren mit einem Carbonsäurehalogenid der allgemeinen Formel
   worin R 1  die genannte Bedeutung hat und X ein Halogenatom bedeutet, zu einem racemischen oder optisch aktiven Cyclopenten-4-carbonsäurederivat der allgemeinen Formel
   acyliert und dieses zum gewünschten Produkt gemäss Formel XIII reduziert.",LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA-MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KNUT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O'MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/178-166-401-045-978,Patent Application,yes,5,3,44,47,1,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C07C231/18;;C12P41/00;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,3,2,010-356-461-521-74X;;082-533-768-814-738,10.1002/hlca.19940770506;;10.1021/jo00119a044,"HILDEBRAND, S. ET AL.: ""A Short Synthesis of (-)-Carbovir."", HELV. CHIM. ACTA, vol. 77, no. 5, 1994, pages 1236 - 1240, XP002109189;;CAMPBELL J. A. ET AL.: ""Chirospecific Synthesis of Precursors of Cyclopentane and Cyclopentene Carbocyclic Nuceosides by [3+3]-Coupling and Transannular Alkylation."", J. ORG. CHEM., vol. 60, 1995, pages 4602 - 4616, XP002041314;;CHEMICAL ABSTRACTS, vol. 107, no. 5, 3 August 1987, Columbus, Ohio, US; abstract no. 39244, ALLAN, ROBIN D. ET AL: "".gamma.-Aminobutyric acid. Synthesis of analogs of GABA. XV. Preparation and resolution of some potent cyclopentene and cyclopentane derivatives"" XP002113019",DISCONTINUED
100,US,A1,US 2014/0148944 A1,046-825-327-526-350,2014-05-29,2014,US 201313909782 A,2013-06-04,US 201313909782 A;;US 67772010 A;;US 2008/0010715 W;;US 96005007 P;;US 7186008 P,2007-09-13,Facility Wide Mixed Mail Sorting and/or Sequencing System and Components and Methods Thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MARKS KENNETH;;MICHA JAMIE;;NASAKAITUS JOHN;;OLVER WILLIAM;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLIAMS BRUCE;;ZIMMER KEVIN,LOCKHEED MARTIN CORPORATION (2013-08-14),https://lens.org/046-825-327-526-350,Patent Application,yes,0,20,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C3/00,700/224,0,0,,,,INACTIVE
101,CZ,A3,CZ 145898 A3,193-792-350-838-653,1998-12-16,1998,CZ 145898 A,1998-05-11,CH 111697 A;;CH 274097 A,1997-05-13,"PROCESS FOR PREPARING (1S,4R)- OR (1R,4S)-4-(2-AMINO-6-CHLORO-9-H-PURIN-9-YL)-2-CYKLOPENTENE-1-METHANOL",,LONZA AG,BERNEGGER CHRISTINE DR;;URBAN EVA MARIA;;BIRCH OLWEN MARY DR;;BURGDORF KURT;;BRUX FRANK;;ETTER KAY-SARA;;BOSSARD PIERRE DR;;BRIEDEN WALTER DR;;DUC LAURENT DR;;GORDON JOHN;;O MURCHU COLM DR;;GUGGISBERG YVES DR,,https://lens.org/193-792-350-838-653,Patent Application,no,0,0,44,47,0,C07B2200/07;;C07C231/18;;C07C233/23;;C07C271/24;;C07D209/94;;C12P13/001;;C12P13/02;;C12P17/182;;C07C2601/10;;C07D473/32;;C07D473/40;;C12P13/001;;C12P13/02;;C12P17/182;;C07C231/18;;C07D209/94;;C12P13/02;;C07B2200/07;;C07C271/24;;C12P13/001;;C12P17/182;;C07C233/23;;C07C2601/10,C12P41/00;;C07C231/18;;C07C231/20;;C07C233/23;;C07C271/24;;C07D209/94;;C07D233/04;;C07D233/74;;C07D235/02;;C07D237/06;;C07D239/70;;C07D473/40;;C12P13/00;;C12P13/02;;C12P17/18;;C12R1/01;;C12R1/05;;C12R1/06;;C12R1/09;;C12R1/19;;C12R1/38,,0,0,,,,EXPIRED
102,WO,A1,WO 2009/035694 A1,041-678-266-814-80X,2009-03-19,2009,US 2008/0010715 W,2008-09-12,US 96005007 P;;US 7186008 P,2007-09-13,FACILITY WIDE MIXED MAIL SORTING AND/OR SEQUENCING SYSTEM AND COMPONENTS AND METHODS THEREOF,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP;;BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;MARKS KENNETH;;NASAKIATUS JOHN;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHON;;WILLAMS BRUCE;;OLVER WILLIAM;;SOLOWIEJ CLIFFORD;;HARTMAN JOHN;;MICHA JAMIE;;ZIMMER KEVIN;;SENSENIG GERALD;;BOSSARD MATTHEW,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;MARKS KENNETH;;NASAKIATUS JOHN;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHON;;WILLAMS BRUCE;;OLVER WILLIAM;;SOLOWIEJ CLIFFORD;;HARTMAN JOHN;;MICHA JAMIE;;ZIMMER KEVIN;;SENSENIG GERALD;;BOSSARD MATTHEW,,https://lens.org/041-678-266-814-80X,Patent Application,yes,8,17,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C5/00,,1,0,,,See also references of EP 2195123A4,PENDING
103,EP,B1,EP 2195123 B1,033-433-834-801-99X,2018-05-16,2018,EP 08830359 A,2008-09-12,US 2008/0010715 W;;US 96005007 P;;US 7186008 P,2007-09-13,ACILITY WIDE MIXED MAIL SORTING AND/OR SEQUENCING SYSTEM,,LOCKHEED CORP,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;MARKS KENNETH;;NASAKIATUS JOHN;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLAMS BRUCE;;OLVER WILLIAM;;SOLOWIEJ CLIFFORD;;HARTMAN JOHN;;MICHA JAMIE;;ZIMMER KEVIN;;SENSENIG GERALD;;BOSSARD MATTHEW,,https://lens.org/033-433-834-801-99X,Granted Patent,yes,6,1,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C3/00,,0,0,,,,ACTIVE
104,US,B2,US 8457781 B2,072-308-039-580-333,2013-06-04,2013,US 67772008 A,2008-09-12,US 67772008 A;;US 7186008 P;;US 96005007 P;;US 2008/0010715 W,2007-09-13,Facility wide mixed mail sorting and/or sequencing system and components and methods thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MARKS KENNETH;;MICHA JAMIE;;NASAKAITUS JOHN;;OLVER WILLIAM;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLIAMS BRUCE;;ZIMMER KEVIN;;LOCKHEED CORP,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MARKS KENNETH;;MICHA JAMIE;;NASAKAITUS JOHN;;OLVER WILLIAM;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLIAMS BRUCE;;ZIMMER KEVIN,LOCKHEED MARTIN CORPORATION (2008-10-03),https://lens.org/072-308-039-580-333,Granted Patent,yes,18,76,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C5/00,700/224,2,0,,,"Extended European Search Report for Application No. 08830359.9 dated Jun. 21, 2012.;;Written Opinion and International Search Report for PCT/US2008/010715.",ACTIVE
105,US,A1,US 2011/0046775 A1,167-387-307-263-696,2011-02-24,2011,US 67772008 A,2008-09-12,US 67772008 A;;US 7186008 P;;US 96005007 P;;US 2008/0010715 W,2007-09-13,Facility Wide Mixed Mail Sorting and/or Sequencing System and Components and Methods Thereof,"The invention generally relates to a facility wide sorting and/or sequencing system for improving product processing operations and, more particularly, to a facility wide system and related functionality for simultaneously sorting and sequencing mixed mail pieces such as, for example, flats and letter mail pieces. The flats and letter mail pieces are placed in frames so that all types of mail pieces can be sorted and/or sequenced simultaneously through merging and diverting a stream of filled trays into and out of different streams at a full or substantially full transport speed.",LOCKHEED CORP,BAILEY DAVID;;BENNINGER DAVID;;BLACKWELL WAYNE;;BOSSARD MATTHEW;;DALTON BRYAN;;ERB THOMAS;;FINNEY MICHAEL;;GAUG MARK;;HARTMAN JOHN;;MARKS KENNETH;;MICHA JAMIE;;NASAKAITUS JOHN;;OLVER WILLIAM;;ONDREYKO DANIEL;;PATRICK JOHN;;PORTER JOSEPH;;RIEHLE KALON;;RIESS MICHAEL;;SCRIVENER LESLIE;;SENSENIG GERALD;;SOLOWIEJ CLIFFORD;;SWEET FRANK;;SWETLAND JAMIE;;WEE JONATHAN;;WILLIAMS BRUCE;;ZIMMER KEVIN,LOCKHEED MARTIN CORPORATION (2008-10-03),https://lens.org/167-387-307-263-696,Patent Application,yes,16,174,12,12,0,B07C3/00;;Y10S209/90;;G06Q10/08;;B07C5/00;;G06Q10/08;;B07C3/00;;Y10S209/90;;B07C5/36;;B65G15/00;;B65G33/02;;B65G47/46;;B65G47/52;;B07C1/20;;B07C3/02;;B65G1/06,B07C3/00,700/224,0,0,,,,ACTIVE
